Datasets:
sovai
/
lobbying_data

Dataset card Data Studio Files
xet
Community
ticker
stringlengths
1
10
date
timestamp[ns]
client
stringlengths
1
80
client_description
stringlengths
2
114
⌀
spend
float64
0
25.9M
transaction_type
stringclasses
7 values
filing_type
stringclasses
7 values
lobby_description
listlengths
0
34
issue_codes
listlengths
1
34
⌀
government_entity_details
listlengths
1
725
⌀
quarter
stringclasses
66 values
effective_date
stringlengths
10
10
termination_date
stringlengths
10
10
⌀
client_state
stringclasses
56 values
client_country
stringclasses
40 values
client_id
int64
12
10M
government_lobby
float64
0
1
⌀
performing_own_lobbying
float64
0
1
⌀
registrant_dt_updated
stringlengths
32
32
registrant_name
stringlengths
3
99
registrant_address
stringlengths
32
87
registrant_id
int64
33
401M
registrant_description
stringlengths
2
103
⌀
registrant_contact_name
stringlengths
0
34
registrant_house_registrant_id
float64
12.7k
401M
⌀
registrant_contact_telephone
stringlengths
0
16
lobbyist_full_names
listlengths
1
272
⌀
lobbyist_ids
listlengths
1
272
⌀
previous_goverment_positions
listlengths
1
272
⌀
lobbyist_new_statuses
listlengths
1
272
⌀
client_url
stringlengths
44
45
registrant_url
stringlengths
45
52
filing_url
stringlengths
88
88
filing_id
stringlengths
36
36
unique_id
stringlengths
46
53
match
stringlengths
1
80
date_time
timestamp[ns]
YNCHF
2008-10-09T00:00:00
astellas pharma us, inc.
null
260,000
a
service_provided
[ "H.R. 6432, Animal Drug User Fee Amendments Act of 2008; S. 2313 and H.R. 3697, the Strategies to Address Antimicrobial Resistance (STAAR Act); S. 2278, the Community and Healthcare Associated Infections (CHAI) Reduction Act; S. 3560, QI Program Supplemental Funding Act of 2008; S. Res. 454 and H. Res. 988, designating March 2008 as MRSA Awareness Month; Issues related to antibiotics and infectious dissease control.", "H.R. 6331, the Medicare Improvements for Patients and Providers Act of 2008; S. 1887, Medicare Access to Critical Medications Act and HR 3061, Amending Title XVIII of the SSA to ensure access to critical medications under Medicare Part D; S. 1951 and H.R. 3700, the Fair Medicaid Drug Payment Act; S. 2320 and H.R. 3282, the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007; Issues related to implementation of Section 5001 (c) of the Deficit Reduction Act of 2005; Issues related to Medicare coverage of immunosuppressants; Issues related to Medicare Part Ds six classes of clinical concern; Issues related to Medicaid payment for hospital-acquired conditions." ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2008-Q3
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA", "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA" ]
[ 40398, 40403, 40398, 40403 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/01cb7dc0-a9f8-4696-8f9a-234bfffb1c38/print/
01cb7dc0-a9f8-4696-8f9a-234bfffb1c38
01cb7dc0-a9f8-4696-8f9a-234bfffb1c38_40032268_188248
astellas pharma us, inc.
2008-10-09T21:34:25
YNCHF
2008-10-16T00:00:00
astellas pharma us, inc.
null
60,000
lobbying_income
service_provided
[ "S. 2313 and H.R. 3697, The Strategies to Address Antimicrobial Resistyance (STAAR Act); S. 2278, The Community and Healthcare Associated Infections (CHAI) Reduction Act; H. Res. 988 and S. Res. 454 MRSA Awareness Month. H. R. 6432, Animal Drug User Fee Amendments of 2008; S. 3560, Q1 Program Suplemental Funding Act of 2008, provisions regarding antibiotics.", "Issues related to the implementation of Section 501 (c) of the 2005 Deficit Reduction Act; S. 1951 and H.R. 3700, The Fair Medicaid Drug Payment Act, Section 2 (b) Prior Authorization Programs; S. 1887. and H.R. 3061 Amending Title XVIII of the Social Security Act to ensure access to critical medications under Medicare Part D; H.R. 6331, The Medicare Improvements for Patients and Providers Act; provisions relating to six classes of clinical concern under Medicare Part D." ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2008-Q3
2007-07-01
null
IL
US
1,002,983
0
null
2024-01-30T12:37:26.892278-05:00
ML STRATEGIES, LLC
555 12th Street NW, Suite 1100, Washington, DC, 20004, US
25,603
Government relations consulting firm
KENISHA RUSSELL
33,962
+1 202-434-7310
[ "JEREMY RABINOVITZ (Chief of Staff to Congresswoman Lois Capps)", "DAVID LEITER", "JEREMY RABINOVITZ (Chief of Staff - Congresswoman Lois Capps)", "DAVID LEITER" ]
[ 31268, 3709, 31268, 3709 ]
[ "Chief of Staff to Congresswoman Lois Capps", null, "Chief of Staff - Congresswoman Lois Capps", null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/133380/
https://lda.senate.gov/api/v1/registrants/25603/
https://lda.senate.gov/filings/public/filing/2d5df22e-c76b-47de-a19e-ce0d9b44bfc6/print/
2d5df22e-c76b-47de-a19e-ce0d9b44bfc6
2d5df22e-c76b-47de-a19e-ce0d9b44bfc6_25603_133380
astellas pharma us, inc.
2008-10-16T15:28:36
YNCHF
2008-10-17T00:00:00
astellas pharma us
Pharmaceutical company
45,000
lobbying_income
service_provided
[ "PHARMACEUTICAL AND LIFE SCIENCES ISSUES", "REIMBURSEMENT ISSUES" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "136 - Centers For Medicare and Medicaid Services (CMS)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "136 - Centers For Medicare and Medicaid Services (CMS)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2008-Q3
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "AARON COHEN (POLICY ADVISOR, SEN. ENSIGN & BRYAN)", "JODIE LOCKHART", "JENNIFER VESEY ROSSMAN (POLICY ADVISOR, SEN. RICK SANTORUM)", "JEFFREY J KIMBELL", "AARON COHEN (POLICY ADVISOR, SEN. ENSIGN & BRYAN)", "JODIE LOCKHART", "JENNIFER VESEY ROSSMAN (POLICY ADVISOR, SEN. RICK SANTORUM)" ]
[ 42442, 35755, 51434, 39999, 42442, 35755, 51434, 39999 ]
[ null, "POLICY ADVISOR, SEN. ENSIGN & BRYAN", null, "POLICY ADVISOR, SEN. RICK SANTORUM", null, "POLICY ADVISOR, SEN. ENSIGN & BRYAN", null, "POLICY ADVISOR, SEN. RICK SANTORUM" ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/f65ccfce-b4b7-450b-b020-19cef18ecc22/print/
f65ccfce-b4b7-450b-b020-19cef18ecc22
f65ccfce-b4b7-450b-b020-19cef18ecc22_46038_153900
astellas pharma us
2008-10-17T14:52:42
YNCHF
2008-10-17T00:00:00
astellas pharma us
Pharmaceutical company
30,000
lobbying_income
service_provided
[ "Issues related to: Antibiotic exclusivity and Infectious disease control; H.R. 6432, Animal Drug User Fee Amendments Act of 2008; S. 2313 and H.R. 3697, the Strategies to Address Antimicrobial Resistance (STAAR Act); S. 3560, QI Program Supplemental Funding Act of 2008; S Res 454 and H Res 988, designating March 2008 as MRSA Awareness Month", "Issues related to: Medicare coverage of immunosuppressants, Medicare Part D's six classes of clinical concern, Medicaid payment for hospital-acquired conditions; The Medicare Improvements for Patients and Providers Act Technical Corrections Act; S. 1887, Medicare Access to Critical Medications Act and HR 3061, Amending Title XVIII of the SSA to ensure access to critical medications under Medicare Part D; S. 1951 and H.R. 3700, the Fair Medicaid Drug Payment Act\nS. 2320 and H.R. 3282, the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007\nIssues related to implementation of Section 5001(c) of the Deficit Reduction Act of 2005" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2008-Q3
2007-11-13
null
VA
US
1,662
0
0
2024-04-09T15:07:31.994474-04:00
CAPITOL HILL CONSULTING GROUP
926 Pennsylvania Ave, SE, Washington, DC, 20003, US
72,053
Government Relations Firm
TAZEEN AHMAD
35,843
+1 202-488-0101
[ "STEVEN E IRIZARRY", "AMANDA HILL", "BILL K BREWSTER", "STEVEN E IRIZARRY", "AMANDA HILL", "BILL K BREWSTER" ]
[ 38987, 35746, 11778, 38987, 35746, 11778 ]
[ null, null, null, null, null, null ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/165609/
https://lda.senate.gov/api/v1/registrants/72053/
https://lda.senate.gov/filings/public/filing/efe82ee8-f4d2-4c26-9c4b-b8301678b379/print/
efe82ee8-f4d2-4c26-9c4b-b8301678b379
efe82ee8-f4d2-4c26-9c4b-b8301678b379_72053_165609
astellas pharma us
2008-10-17T15:03:24
YNCHF
2008-10-20T00:00:00
astellas pharma us, inc.
Pharmaceutical manufacturing and marketing.
5,000
lobbying_income
retainer
[]
null
null
2008-Q3
2010-06-01
null
IL
US
1,003,785
0
0
2024-01-30T20:18:32.515056-05:00
ARNOLD & PORTER KAYE SCHOLER LLP
601 Massachusetts Ave. NW, Washington, DC, 20001, US
4,301
Law firm
NICHOLAS TOWNSEND
31,381
+1 202-942-5249
null
null
null
null
https://lda.senate.gov/api/v1/clients/104567/
https://lda.senate.gov/api/v1/registrants/4301/
https://lda.senate.gov/filings/public/filing/98bead04-9daa-4d71-861a-f26c5bc725a3/print/
98bead04-9daa-4d71-861a-f26c5bc725a3
98bead04-9daa-4d71-861a-f26c5bc725a3_4301_104567
astellas pharma us, inc.
2008-10-20T13:16:24
YNCHF
2009-01-14T00:00:00
astellas pharma us
Pharmaceutical company
0
lobbying_income
service_provided
[ "Issues related to: Antibiotic exclusivity and Infectious disease control; H.R. 6432, S. 2313 and H.R. 3697, the Strategies to Address Antimicrobial Resistance (STAAR Act); S. 3560, QI Program Supplemental Funding Act of 2008; S Res 454 and H Res 988, designating March 2008 as MRSA Awareness Month", "Issues related to: Medicare coverage of immunosuppressants, Medicare Part D's six classes of clinical concern, Medicaid payment for hospital-acquired conditions; The Medicare Improvements for Patients and Providers Act Technical Corrections Act; S. 1887, Medicare Access to Critical Medications Act and HR 3061, Amending Title XVIII of the SSA to ensure access to critical medications under Medicare Part D; S. 1951 and H.R. 3700, the Fair Medicaid Drug Payment Act; S. 2320 and H.R. 3282, the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007\nIssues related to implementation of Section 5001(c) of the Deficit Reduction Act of 2005" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2008-Q4
2007-11-13
null
VA
US
1,662
0
0
2024-04-09T15:07:31.994474-04:00
CAPITOL HILL CONSULTING GROUP
926 Pennsylvania Ave, SE, Washington, DC, 20003, US
72,053
Government Relations Firm
TAZEEN AHMAD
35,843
+1 202-488-0101
[ "STEVEN E IRIZARRY", "AMANDA HILL", "BILL K BREWSTER", "STEVEN E IRIZARRY", "AMANDA HILL", "BILL K BREWSTER" ]
[ 38987, 35746, 11778, 38987, 35746, 11778 ]
[ null, null, null, null, null, null ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/165609/
https://lda.senate.gov/api/v1/registrants/72053/
https://lda.senate.gov/filings/public/filing/0b8f0a23-740c-4944-8b53-efa868f794a6/print/
0b8f0a23-740c-4944-8b53-efa868f794a6
0b8f0a23-740c-4944-8b53-efa868f794a6_72053_165609
astellas pharma us
2009-01-14T16:20:46
YNCHF
2009-01-15T00:00:00
astellas pharma us, inc.
null
60,000
lobbying_income
service_provided
[ "S. 2313 and H.R. 3697, The Strategies to Address Antimicrobial Resistyance (STAAR Act); S. 2278, The Community and Healthcare Associated Infections (CHAI) Reduction Act; H. Res. 988 and S. Res. 454 MRSA Awareness Month. S. 3560, Q1 Program Suplemental Funding Act of 2008, provisions regarding antibiotics.", "Issues related to the implementation of Section 501 (c) of the 2005 Deficit Reduction Act; S. 1951 and H.R. 3700, The Fair Medicaid Drug Payment Act, Section 2 (b) Prior Authorization Programs; S. 1887 and H.R. 3061 Amending Title XVIII of the Social Security Act to ensure access to critical medications under Medicare Part D." ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2008-Q4
2007-07-01
null
IL
US
1,002,983
0
null
2024-01-30T12:37:26.892278-05:00
ML STRATEGIES, LLC
555 12th Street NW, Suite 1100, Washington, DC, 20004, US
25,603
Government relations consulting firm
KENISHA RUSSELL
33,962
+1 202-434-7310
[ "JEREMY RABINOVITZ (Chief of Staff - Congresswoman Lois Capps)", "DAVID LEITER", "JEREMY RABINOVITZ (Chief of Staff - Congresswoman Lois Capps)", "DAVID LEITER" ]
[ 31268, 3709, 31268, 3709 ]
[ "Chief of Staff - Congresswoman Lois Capps", null, "Chief of Staff - Congresswoman Lois Capps", null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/133380/
https://lda.senate.gov/api/v1/registrants/25603/
https://lda.senate.gov/filings/public/filing/50c20557-07f8-4a30-8dd8-8aca94801b34/print/
50c20557-07f8-4a30-8dd8-8aca94801b34
50c20557-07f8-4a30-8dd8-8aca94801b34_25603_133380
astellas pharma us, inc.
2009-01-15T18:55:29
YNCHF
2009-01-16T00:00:00
astellas pharma us, inc.
null
260,000
a
service_provided
[ "S. 2313 and H.R. 3697, the Strategies to Address Antimicrobial Resistance (STAAR Act); S. 2278, the Community and Healthcare Associated Infections (CHAI) Reduction Act; S. Res. 454 and H. Res. 988, designating March 2008 as MRSA Awareness Month; Issues related to antibiotics and infectious dissease control.", "S. 3560, QI Program Supplemental Funding Act of 2008, Amending Title XVIII of the SSA to ensure access to critical medications under Medicare Part D; S. 1951 and H.R. 3700, the Fair Medicaid Drug Payment Act; S. 2320 and H.R. 3282, the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007; Issues related to implementation of Section 5001 (c) of the Deficit Reduction Act of 2005; Issues related to Medicare coverage of immunosuppressants; Issues related to Medicare Part Ds six classes of clinical concern; Issues related to Medicaid payment for hospital-acquired conditions." ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2008-Q4
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA", "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA" ]
[ 40398, 40403, 40398, 40403 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/e32dbd33-4470-4af3-b483-b0bc4723a1ca/print/
e32dbd33-4470-4af3-b483-b0bc4723a1ca
e32dbd33-4470-4af3-b483-b0bc4723a1ca_40032268_188248
astellas pharma us, inc.
2009-01-16T23:32:55
YNCHF
2009-01-20T00:00:00
astellas pharma us
Pharmaceutical company
45,000
lobbying_income
service_provided
[ "REIMBURSEMENT ISSUES", "PHARMACEUTICAL AND LIFE SCIENCES ISSUES" ]
[ "MMM - Medicare/Medicaid", "HCR - Health Issues" ]
[ "136 - Centers For Medicare and Medicaid Services (CMS)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "136 - Centers For Medicare and Medicaid Services (CMS)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2008-Q4
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "AARON COHEN (POLICY ADVISOR, SEN. ENSIGN & BRYAN)", "JODIE LOCKHART", "JENNIFER VESEY ROSSMAN (POLICY ADVISOR, SEN. RICK SANTORUM)", "JEFFREY J KIMBELL", "AARON COHEN (POLICY ADVISOR, SEN. ENSIGN & BRYAN)", "JODIE LOCKHART", "JENNIFER VESEY ROSSMAN (POLICY ADVISOR, SEN. RICK SANTORUM)" ]
[ 42442, 35755, 51434, 39999, 42442, 35755, 51434, 39999 ]
[ null, "POLICY ADVISOR, SEN. ENSIGN & BRYAN", null, "POLICY ADVISOR, SEN. RICK SANTORUM", null, "POLICY ADVISOR, SEN. ENSIGN & BRYAN", null, "POLICY ADVISOR, SEN. RICK SANTORUM" ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/590a2a8e-2c02-4233-8fe4-9c70e2be6b5f/print/
590a2a8e-2c02-4233-8fe4-9c70e2be6b5f
590a2a8e-2c02-4233-8fe4-9c70e2be6b5f_46038_153900
astellas pharma us
2009-01-20T14:46:13
YNCHF
2009-01-22T00:00:00
astellas pharma us, inc.
Pharmaceutical manufacturing and marketing.
5,000
lobbying_income
modify_termination
[]
null
null
2008-Q4
2010-06-01
2008-10-01
IL
US
1,003,785
0
0
2024-01-30T20:18:32.515056-05:00
ARNOLD & PORTER KAYE SCHOLER LLP
601 Massachusetts Ave. NW, Washington, DC, 20001, US
4,301
Law firm
NICHOLAS TOWNSEND
31,381
+1 202-942-5249
null
null
null
null
https://lda.senate.gov/api/v1/clients/104567/
https://lda.senate.gov/api/v1/registrants/4301/
https://lda.senate.gov/filings/public/filing/3cb38bbe-753f-44d4-a3a8-ba5dc2c1296a/print/
3cb38bbe-753f-44d4-a3a8-ba5dc2c1296a
3cb38bbe-753f-44d4-a3a8-ba5dc2c1296a_4301_104567
astellas pharma us, inc.
2009-01-22T14:58:17
YNCHF
2009-04-01T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "Americas Healthy Future Act of 2009. S. 1679, Affordable Health Choices Act. H.R. 3200, America's Affordable Health Choices Act of 2009. H.R. 1458/S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Incentives for companies to develop anti-biotics/anti-infectives with FDA priority reveiw voucher. Issues pertaining to community and hospital acquired infections (HAC). 340b program.", "Americas Healthy Future Act of 2009. S. 1679, Affordable Health Choices Act. H.R. 3200, America's Affordable Health Choices Act of 2009. H.R. 1458/S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Issues pertaining to community and hospital acquired infections (HAC)." ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2009-Q4
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JONATHON JONES", "JOHN MICHAEL GONZALEZ (Chief of Staff, Rep. Melissa Bean)", "SHEILA MURPHY (Legislative Director, Senator Klobuchar)", "SEAN RICHARDSON", "JONATHON JONES", "JOHN MICHAEL GONZALEZ (Chief of Staff, Rep. Melissa Bean)", "SHEILA MURPHY (Legislative Director, Senator Klobuchar)", "SEAN RICHARDSON" ]
[ 26450, 47178, 41354, 6542, 26450, 47178, 41354, 6542 ]
[ null, "Chief of Staff, Rep. Melissa Bean", "Legislative Director, Senator Klobuchar", null, null, "Chief of Staff, Rep. Melissa Bean", "Legislative Director, Senator Klobuchar", null ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/b410846c-9bc7-48d7-b96f-21abe35436a2/print/
b410846c-9bc7-48d7-b96f-21abe35436a2
b410846c-9bc7-48d7-b96f-21abe35436a2_20744_127151
astellas pharma us, inc.
null
YNCHF
2009-04-01T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152). Issues related to CMS Outpatient Prospective Payment System (OPPS) rule. H.R. 1178, Ensuring Equal Access to Treatments Act of 2015. S.1466, Ensuring Equal Access to Treatments Act of 2015. Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517). Issues related to drug pricing." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2016-Q4
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SEAN RICHARDSON" ]
[ 47178, 26450, 6542 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/0ada24f7-180d-4fb5-9975-dae98cec476e/print/
0ada24f7-180d-4fb5-9975-dae98cec476e
0ada24f7-180d-4fb5-9975-dae98cec476e_20744_127151
astellas pharma us, inc.
null
YNCHF
2009-04-14T00:00:00
astellas pharma us
Pharmaceutical company
30,000
lobbying_income
service_provided
[ "Issues pertaining to antimicrobial resistance; Issues pertaining to community and healthcare associated infections; Issues pertaining to organ transplantation.", "Issues related to: Medicare coverage of immunosuppressants, Medicare Part D's six classes of clinical concern, Medicaid payment for hospital-acquired conditions; the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Ace of 2007" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2009-Q1
2007-11-13
null
VA
US
1,662
0
0
2024-04-09T15:07:31.994474-04:00
CAPITOL HILL CONSULTING GROUP
926 Pennsylvania Ave, SE, Washington, DC, 20003, US
72,053
Government Relations Firm
TAZEEN AHMAD
35,843
+1 202-488-0101
[ "STEVEN E IRIZARRY", "AMANDA HILL", "BILL K BREWSTER", "STEVEN E IRIZARRY", "AMANDA HILL", "BILL K BREWSTER" ]
[ 38987, 35746, 11778, 38987, 35746, 11778 ]
[ null, null, null, null, null, null ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/165609/
https://lda.senate.gov/api/v1/registrants/72053/
https://lda.senate.gov/filings/public/filing/28475da5-9ddc-452e-9a06-6e2c78f2a123/print/
28475da5-9ddc-452e-9a06-6e2c78f2a123
28475da5-9ddc-452e-9a06-6e2c78f2a123_72053_165609
astellas pharma us
2009-04-14T18:22:17
YNCHF
2009-04-15T00:00:00
astellas pharma us, inc.
null
317,000
a
service_provided
[ "Issues pertaining to antimicrobial resistance; Issues pertaining to community and healthcare associated infections; Issues pertaining to organ transplantation.", "Issues related to the implementation of Section 501(c) of the 2005 Deficit Reduction Act; Issues related to ensuring access to critical medications under Medicare Part D; The Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act." ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2009-Q1
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA", "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA" ]
[ 40398, 40403, 40398, 40403 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/522dbe3f-96fd-4a1f-b024-a3c9519a1217/print/
522dbe3f-96fd-4a1f-b024-a3c9519a1217
522dbe3f-96fd-4a1f-b024-a3c9519a1217_40032268_188248
astellas pharma us, inc.
2009-04-15T14:20:01
YNCHF
2009-04-16T00:00:00
astellas pharma us, inc.
null
60,000
lobbying_income
service_provided
[ "Issues pertaining to Antimicrobial Resistance; Issues pertaining to Community and Healthcare Associated Infections; Issues pertaining to organ transplantation.", "Issues relating to ensuring access to critical medications under Medicare Part D; Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act." ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2009-Q1
2007-07-01
null
IL
US
1,002,983
0
null
2024-01-30T12:37:26.892278-05:00
ML STRATEGIES, LLC
555 12th Street NW, Suite 1100, Washington, DC, 20004, US
25,603
Government relations consulting firm
KENISHA RUSSELL
33,962
+1 202-434-7310
[ "JEREMY RABINOVITZ (Chief of Staff - Congresswoman Lois Capps)", "DAVID LEITER", "JEREMY RABINOVITZ (Chief of Staff - Congresswoman Lois Capps)", "DAVID LEITER" ]
[ 31268, 3709, 31268, 3709 ]
[ "Chief of Staff - Congresswoman Lois Capps", null, "Chief of Staff - Congresswoman Lois Capps", null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/133380/
https://lda.senate.gov/api/v1/registrants/25603/
https://lda.senate.gov/filings/public/filing/c0ca50a9-e1d9-499f-bd39-3d57745f443f/print/
c0ca50a9-e1d9-499f-bd39-3d57745f443f
c0ca50a9-e1d9-499f-bd39-3d57745f443f_25603_133380
astellas pharma us, inc.
2009-04-16T14:30:13
YNCHF
2009-04-20T00:00:00
astellas pharma us
Pharmaceutical company
0
lobbying_income
service_provided
[ "REIMBURSEMENT ISSUES", "PHARMACEUTICAL AND LIFE SCIENCES ISSUES" ]
[ "MMM - Medicare/Medicaid", "HCR - Health Issues" ]
[ "136 - Centers For Medicare and Medicaid Services (CMS)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "136 - Centers For Medicare and Medicaid Services (CMS)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2009-Q1
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "AARON COHEN (POLICY ADVISOR, SEN. ENSIGN & BRYAN)", "JODIE LOCKHART", "JENNIFER VESEY ROSSMAN (POLICY ADVISOR, SEN. RICK SANTORUM)", "JEFFREY J KIMBELL", "AARON COHEN (POLICY ADVISOR, SEN. ENSIGN & BRYAN)", "JODIE LOCKHART", "JENNIFER VESEY ROSSMAN (POLICY ADVISOR, SEN. RICK SANTORUM)" ]
[ 42442, 35755, 51434, 39999, 42442, 35755, 51434, 39999 ]
[ null, "POLICY ADVISOR, SEN. ENSIGN & BRYAN", null, "POLICY ADVISOR, SEN. RICK SANTORUM", null, "POLICY ADVISOR, SEN. ENSIGN & BRYAN", null, "POLICY ADVISOR, SEN. RICK SANTORUM" ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/47ed920a-4fb8-48fc-9d7d-11c2baa9bc4d/print/
47ed920a-4fb8-48fc-9d7d-11c2baa9bc4d
47ed920a-4fb8-48fc-9d7d-11c2baa9bc4d_46038_153900
astellas pharma us
2009-04-20T15:03:40
YNCHF
2009-07-14T00:00:00
astellas pharma us
Pharmaceutical company
30,000
lobbying_income
service_provided
[ "issues pertaining to antimicrobial resistance; community and healthcare associated infections and organ transplantation", "issues related to: Medicare coverage of immunosuppressants; Medicare Part D's six classes of clinical concern, Medicaid payment for hospital-acquired conditions; the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act HR1458/S.565" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2009-Q2
2007-11-13
null
VA
US
1,662
0
0
2024-04-09T15:07:31.994474-04:00
CAPITOL HILL CONSULTING GROUP
926 Pennsylvania Ave, SE, Washington, DC, 20003, US
72,053
Government Relations Firm
TAZEEN AHMAD
35,843
+1 202-488-0101
[ "STEVEN E IRIZARRY", "AMANDA HILL", "BILL K BREWSTER", "STEVEN E IRIZARRY", "AMANDA HILL", "BILL K BREWSTER" ]
[ 38987, 35746, 11778, 38987, 35746, 11778 ]
[ null, null, null, null, null, null ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/165609/
https://lda.senate.gov/api/v1/registrants/72053/
https://lda.senate.gov/filings/public/filing/3ff9c251-c4a2-4069-9c0c-959bcbbcab45/print/
3ff9c251-c4a2-4069-9c0c-959bcbbcab45
3ff9c251-c4a2-4069-9c0c-959bcbbcab45_72053_165609
astellas pharma us
2009-07-14T13:50:38
YNCHF
2009-07-15T00:00:00
astellas pharma us, inc.
null
60,000
lobbying_income
service_provided
[ "Issues pertaining to Antimicrobial Resistance; Issues pertaining to Community and Healthcare Associated Infections; Issues pertaining to organ transplantation.", "Issues relating to ensuring access to critical medications under Medicare Part D, and Medigap Policies; H. R. 1458 and S. 565, Comprehensive Immunosuppressive Drug coverage for Transplant Patients Act; H. R. 574 and S. 254, Medicare Home Infusion Therapy Coverage Act of 2009." ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2009-Q2
2007-07-01
null
IL
US
1,002,983
0
null
2024-01-30T12:37:26.892278-05:00
ML STRATEGIES, LLC
555 12th Street NW, Suite 1100, Washington, DC, 20004, US
25,603
Government relations consulting firm
KENISHA RUSSELL
33,962
+1 202-434-7310
[ "JEREMY RABINOVITZ", "DAVID LEITER", "JEREMY RABINOVITZ", "DAVID LEITER" ]
[ 31268, 3709, 31268, 3709 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/133380/
https://lda.senate.gov/api/v1/registrants/25603/
https://lda.senate.gov/filings/public/filing/a32d8d91-8690-41cb-9730-d415dda0b879/print/
a32d8d91-8690-41cb-9730-d415dda0b879
a32d8d91-8690-41cb-9730-d415dda0b879_25603_133380
astellas pharma us, inc.
2009-07-15T16:09:55
YNCHF
2009-07-17T00:00:00
astellas pharma us, inc.
null
377,000
a
service_provided
[ "Tariff duty suspension", "Issues pertaining to antimicrobial resistance (HR 2400); Issues pertaining to community and healthcare associated infections; Issues pertaining to organ transplantation.", "Issues related to the implementation of Section 501(c) of the 2005 Deficit Reduction Act; Issues related to ensuring access to critical medications under Medicare Part D; Issues related to hospital readmissions/bundling and home infusion therapy coverage (HR 574/S 254); The Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act (HR 1458/S 565)." ]
[ "TRD - Trade (domestic/foreign)", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2009-Q2
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA", "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA", "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA" ]
[ 40398, 40403, 40398, 40403, 40398, 40403 ]
[ null, null, null, null, null, null ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/5b420cd2-ddf7-4049-b7e6-60c49e45ffc2/print/
5b420cd2-ddf7-4049-b7e6-60c49e45ffc2
5b420cd2-ddf7-4049-b7e6-60c49e45ffc2_40032268_188248
astellas pharma us, inc.
2009-07-17T18:07:38
YNCHF
2009-07-20T00:00:00
astellas pharma us
Pharmaceutical company
75,000
lobbying_income
service_provided
[ "PHARMACEUTICAL AND LIFE SCIENCES ISSUES", "REIMBURSEMENT ISSUES" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "136 - Centers For Medicare and Medicaid Services (CMS)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "136 - Centers For Medicare and Medicaid Services (CMS)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2009-Q2
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "JENNIFER VESEY ROSSMAN (POLICY ADVISOR, SEN. RICK SANTORUM)", "JEFFREY J KIMBELL", "JODIE LOCKHART", "JENNIFER VESEY ROSSMAN (POLICY ADVISOR, SEN. RICK SANTORUM)" ]
[ 42442, 51434, 39999, 42442, 51434, 39999 ]
[ null, null, "POLICY ADVISOR, SEN. RICK SANTORUM", null, null, "POLICY ADVISOR, SEN. RICK SANTORUM" ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/be2e0e95-3c3d-4506-a4f8-526862f12ac3/print/
be2e0e95-3c3d-4506-a4f8-526862f12ac3
be2e0e95-3c3d-4506-a4f8-526862f12ac3_46038_153900
astellas pharma us
2009-07-20T15:20:59
YNCHF
2009-07-20T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "Develop. of health care legislation in Sen. Finance Committee. Affordable Health Choices Act. House Tri-Committee draft proposal. H.R. 1458/S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Incentives for companies to develop anti-biotics/anti-infectives with FDA priority reveiw voucher. Issues pertaining to community and hospital acquired infections (HAC).", "Develop. of health care legislation in Sen. Finance Committee. Affordable Health Choices Act. House Tri-Committee draft proposal. H.R. 1458/S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Incentives for companies to develop anti-biotics/anti-infectives with FDA priority reveiw voucher. Issues pertaining to community and hospital acquired infections (HAC)." ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2009-Q2
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JONATHON JONES", "JOHN MICHAEL GONZALEZ (Chief of Staff, Rep. Melissa Bean)", "SHEILA MURPHY (Legislative Director, Senator Klobuchar)", "SEAN RICHARDSON", "JONATHON JONES", "JOHN MICHAEL GONZALEZ (Chief of Staff, Rep. Melissa Bean)", "SHEILA MURPHY (Legislative Director, Senator Klobuchar)", "SEAN RICHARDSON" ]
[ 26450, 47178, 41354, 6542, 26450, 47178, 41354, 6542 ]
[ null, "Chief of Staff, Rep. Melissa Bean", "Legislative Director, Senator Klobuchar", null, null, "Chief of Staff, Rep. Melissa Bean", "Legislative Director, Senator Klobuchar", null ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/f2b7c373-0b94-4b50-a418-022746479720/print/
f2b7c373-0b94-4b50-a418-022746479720
f2b7c373-0b94-4b50-a418-022746479720_20744_127151
astellas pharma us, inc.
2009-07-20T16:33:15
YNCHF
2009-10-07T00:00:00
astellas pharma us
Pharmaceutical company
0
lobbying_income
service_provided
[ "issues pertaining to antimicrobial resistance; community and healthcare associated infections and organ transplantation; STAAR Act", "issues related to Medicare coverage of immunosuppressants; Medicaid payment for hospital-acquired conditions; the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (HR1458/S.565); America's Affordable Health Choices Act (HR3200); America's Healthy Future Act of 2009" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2009-Q3
2007-11-13
null
VA
US
1,662
0
0
2024-04-09T15:07:31.994474-04:00
CAPITOL HILL CONSULTING GROUP
926 Pennsylvania Ave, SE, Washington, DC, 20003, US
72,053
Government Relations Firm
TAZEEN AHMAD
35,843
+1 202-488-0101
[ "STEVEN E IRIZARRY", "BILL K BREWSTER", "AMANDA HILL", "STEVEN E IRIZARRY", "BILL K BREWSTER", "AMANDA HILL" ]
[ 38987, 11778, 35746, 38987, 11778, 35746 ]
[ null, null, null, null, null, null ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/165609/
https://lda.senate.gov/api/v1/registrants/72053/
https://lda.senate.gov/filings/public/filing/f29cb350-81d7-4573-b7fb-798070e4771e/print/
f29cb350-81d7-4573-b7fb-798070e4771e
f29cb350-81d7-4573-b7fb-798070e4771e_72053_165609
astellas pharma us
2009-10-07T15:04:21
YNCHF
2009-10-15T00:00:00
astellas pharma us, inc.
null
0
lobbying_income
service_provided
[ "H. R. 2400, Strategies to Address Antimicrobial Resistance (STAAR) Act; H. R. 3276, American Medical Isotope Production Act.", "H. R. 1458, and S. 565, Comprehensive Immunosuppressive Drug coverage for Transplant Patients Act; H. R. 574 and S. 254, Medicare Home Infusion Therapy Coverage Act of 2009; H. R. 3200, America's Affordable Health Choices Act; S. 1679, Affordable Health Choices Act; America's Healthy Future Act; issues related to immunosuppresive drug coverage and home infusion therapy coverage." ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2009-Q3
2007-07-01
null
IL
US
1,002,983
0
null
2024-01-30T12:37:26.892278-05:00
ML STRATEGIES, LLC
555 12th Street NW, Suite 1100, Washington, DC, 20004, US
25,603
Government relations consulting firm
KENISHA RUSSELL
33,962
+1 202-434-7310
[ "JEREMY RABINOVITZ", "DAVID LEITER", "JEREMY RABINOVITZ", "DAVID LEITER" ]
[ 31268, 3709, 31268, 3709 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/133380/
https://lda.senate.gov/api/v1/registrants/25603/
https://lda.senate.gov/filings/public/filing/0d7a060a-8662-484a-bb56-60097ecaa982/print/
0d7a060a-8662-484a-bb56-60097ecaa982
0d7a060a-8662-484a-bb56-60097ecaa982_25603_133380
astellas pharma us, inc.
2009-10-15T19:25:52
YNCHF
2009-10-16T00:00:00
astellas pharma us, inc.
null
382,500
a
service_provided
[ "Issues pertaining to antimicrobial resistance (HR 2400); issues pertaining to community and healthcare associated infections; issues pertaining to medical isotopes (HR 3276); issues related to 340B program; The Affordable Health Choices Act (S. 1679)", "Issues related to the implementation of Section 501(c) of the 2005 Deficit Reduction Act; Issues related to hospital readmissions/bundling and home infusion therapy coverage (HR 574/S254): The Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act (HR 1458/S 565); Issues related to Medicare Hospital Outpatient Prospective Payment System; America's Affordable Health Choices Act (HR 3200): America's Healthy Future Act" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2009-Q3
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA", "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA" ]
[ 40398, 40403, 40398, 40403 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/220d302a-be0b-45fc-bacf-47a33bef20d1/print/
220d302a-be0b-45fc-bacf-47a33bef20d1
220d302a-be0b-45fc-bacf-47a33bef20d1_40032268_188248
astellas pharma us, inc.
2009-10-16T12:42:56
YNCHF
2009-10-19T00:00:00
astellas pharma us
Pharmaceutical company
75,000
lobbying_income
service_provided
[ "REIMBURSEMENT ISSUES", "PHARMACEUTICAL AND LIFE SCIENCES ISSUES" ]
[ "MMM - Medicare/Medicaid", "HCR - Health Issues" ]
[ "136 - Centers For Medicare and Medicaid Services (CMS)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "136 - Centers For Medicare and Medicaid Services (CMS)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2009-Q3
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "JENNIFER VESEY ROSSMAN (POLICY ADVISOR, SEN. RICK SANTORUM)", "JEFFREY J KIMBELL", "JODIE LOCKHART", "JENNIFER VESEY ROSSMAN (POLICY ADVISOR, SEN. RICK SANTORUM)" ]
[ 42442, 51434, 39999, 42442, 51434, 39999 ]
[ null, null, "POLICY ADVISOR, SEN. RICK SANTORUM", null, null, "POLICY ADVISOR, SEN. RICK SANTORUM" ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/d6bcdb72-965a-4852-bab5-73607b4b85af/print/
d6bcdb72-965a-4852-bab5-73607b4b85af
d6bcdb72-965a-4852-bab5-73607b4b85af_46038_153900
astellas pharma us
2009-10-19T21:00:18
YNCHF
2009-10-20T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "Americas Healthy Future Act of 2009. S. 1679, Affordable Health Choices Act. H.R. 3200, America's Affordable Health Choices Act of 2009. H.R. 1458/S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Incentives for companies to develop anti-biotics/anti-infectives with FDA priority reveiw voucher. Issues pertaining to community and hospital acquired infections (HAC). 340b program.", "Americas Healthy Future Act of 2009. S. 1679, Affordable Health Choices Act. H.R. 3200, America's Affordable Health Choices Act of 2009. H.R. 1458/S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Issues pertaining to community and hospital acquired infections (HAC)." ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2009-Q3
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JONATHON JONES", "JOHN MICHAEL GONZALEZ (Chief of Staff, Rep. Melissa Bean)", "SHEILA MURPHY (Legislative Director, Senator Klobuchar)", "SEAN RICHARDSON", "JONATHON JONES", "JOHN MICHAEL GONZALEZ (Chief of Staff, Rep. Melissa Bean)", "SHEILA MURPHY (Legislative Director, Senator Klobuchar)", "SEAN RICHARDSON" ]
[ 26450, 47178, 41354, 6542, 26450, 47178, 41354, 6542 ]
[ null, "Chief of Staff, Rep. Melissa Bean", "Legislative Director, Senator Klobuchar", null, null, "Chief of Staff, Rep. Melissa Bean", "Legislative Director, Senator Klobuchar", null ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/0e19876b-2798-4c99-9a73-2395a1d33996/print/
0e19876b-2798-4c99-9a73-2395a1d33996
0e19876b-2798-4c99-9a73-2395a1d33996_20744_127151
astellas pharma us, inc.
2009-10-20T19:16:12
YNCHF
2010-04-13T00:00:00
astellas pharma us, inc.
null
50,000
lobbying_income
service_provided
[ "H. R. 2221, Data Accountability and Trust Act.", "H. R. 2400, Strategies to Address Antimicrobial Resistance (STARR) Act; H. R. 3276, American Medical Isotope Production Act, 21st Century ALERT (Access to Life-Saving Early Detection, Research and Treatment) Act.", "Issues related to CPT codes for Myocardial Perfusion Imaging; H. R. 4371; H. R. 1458, and S. 565, Comprehensive Immunosuppressive Drug coverage for Transplant Patients Act; H. R. 574 & S. 254, Medicare Home Infusion Therapy Coverage Act of 2009; H. R 3962, Affordable Health Care for America Act; H. R. 3590, Patient Protection &Affordable Care Act; H. R. 4872 \nThe Health Care and Education Reconciliation Act; issues related to immunosuppresive drug coverage & home infusion coverage." ]
[ "TEC - Telecommunications", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2010-Q1
2007-07-01
null
IL
US
1,002,983
0
null
2024-01-30T12:37:26.892278-05:00
ML STRATEGIES, LLC
555 12th Street NW, Suite 1100, Washington, DC, 20004, US
25,603
Government relations consulting firm
KENISHA RUSSELL
33,962
+1 202-434-7310
[ "JEREMY RABINOVITZ", "JEREMY RABINOVITZ", "JEREMY RABINOVITZ", "DAVID LEITER", "JOHN T KOUTSOUMPAS" ]
[ 31268, 31268, 31268, 3709, 52145 ]
[ null, null, null, null, null ]
[ false, false, false, false, true ]
https://lda.senate.gov/api/v1/clients/133380/
https://lda.senate.gov/api/v1/registrants/25603/
https://lda.senate.gov/filings/public/filing/b439bf8b-df71-402f-b4f5-cdcfbe67b792/print/
b439bf8b-df71-402f-b4f5-cdcfbe67b792
b439bf8b-df71-402f-b4f5-cdcfbe67b792_25603_133380
astellas pharma us, inc.
2010-04-13T15:57:09
YNCHF
2010-04-19T00:00:00
astellas pharma us
Pharmaceutical company
30,000
lobbying_income
service_provided
[ "Issues pertaining to antimicrobial resistance; community and healthcare associated infections and organ transplantation; STARR Act; Drug Importation; Follow-on Biologics", "Issues related to Medicare coverage of immunosuppresants; Medicaid payment for hospital-acquired conditions; the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (H.R. 1458/S.565); American's Affordable Health Choices Act (H.R. 300); America's Healthy Future Act of 2009; Affordable Healthcare for America Act (H.R. 3862); Patient Protection and Affordable Care Act (H.R. 3590)" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2010-Q1
2007-11-13
null
VA
US
1,662
0
0
2024-04-09T15:07:31.994474-04:00
CAPITOL HILL CONSULTING GROUP
926 Pennsylvania Ave, SE, Washington, DC, 20003, US
72,053
Government Relations Firm
TAZEEN AHMAD
35,843
+1 202-488-0101
[ "STEVEN E IRIZARRY", "BILL K BREWSTER", "STEVEN E IRIZARRY", "BILL K BREWSTER" ]
[ 38987, 11778, 38987, 11778 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/165609/
https://lda.senate.gov/api/v1/registrants/72053/
https://lda.senate.gov/filings/public/filing/4a0b004e-b0cc-46d0-895b-c13f83487aa3/print/
4a0b004e-b0cc-46d0-895b-c13f83487aa3
4a0b004e-b0cc-46d0-895b-c13f83487aa3_72053_165609
astellas pharma us
2010-04-19T22:42:51
YNCHF
2010-04-19T00:00:00
astellas pharma us, inc.
null
700,000
a
service_provided
[ "Issues related to Data Accountability bill (HR 2221)", "Issues pertaining to antimicrobial resistance (Strategies to Address Antimicrobial Resistance Act, (HR 2400))\nIssues pertaining to community and healthcare associated infections \nIssues pertaining to medical isotopes (American Medical Isotopes Production Act of 2009 (HR 3276)) \nIssues related to the study of clinical effectiveness for immunosuppressant drugs Issues related to 340B program, follow on biologics, hospital readmissions/bundling and home infusion therapy coverage, the Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act (HR 1458/S 565), the Patient Protection and Affordable Care Act (HR 3590), Affordable Health Care for America Act (HR 3962), the Health Care and Education Reconciliation Act of 2010 (HR4872).\n\nIssues related to comparative clinical effectiveness of immunosuppressant drugs.\n\nIssues related to oncology coverage, the 21st Century Cancer ALERT (\"Access to Life-Saving Early detection, Research and Treatment\" Act (HR1844)).\n\nIssues related to comparative clinical effectiveness", "Issues related to hospital readmissions/bundling and home infusion therapy coverage, (the Medicare Home Infusion Therapy \nCoverageAct of 2009 (HR 574/S 254))\n\nThe Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act (HR 1458/S 565) Issues related to Medicare physician payment system (to amend title XVIII of the Social Security Act to continue using 2009 Medicare practice expense relative value units for certain cardiology services, (HR 4371)), and CPT codes for myocardial perfusion imaging. \n\nThe Health Care and Education Reconciliation Act of 2010 (HR 4872), the Patient Protection and Affordable Care (HR 3590),\nand the Affordable Health Care for America Act (HR 3962).\n\nIssues related to oncology coverage and medicare clinical trials, the 21st Century Cancer ALERT (\"Access to Life-Saving Early detection, Research and Treatment\" Act (HR1844)).", "Tariff duty suspension for RSD 1235, (a bill to extend temporarily the suspension of duty on RSD 1235, (S 2753))" ]
[ "TEC - Telecommunications", "HCR - Health Issues", "MMM - Medicare/Medicaid", "TAR - Tariff (miscellaneous tariff bills)" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2010-Q1
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA", "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA", "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA", "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA" ]
[ 40398, 40403, 40398, 40403, 40398, 40403, 40398, 40403 ]
[ null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/4c688f49-4ae8-457c-83b8-e25fb9ef65f4/print/
4c688f49-4ae8-457c-83b8-e25fb9ef65f4
4c688f49-4ae8-457c-83b8-e25fb9ef65f4_40032268_188248
astellas pharma us, inc.
2010-04-19T18:11:10
YNCHF
2010-04-20T00:00:00
astellas pharma us
Pharmaceutical company
60,000
lobbying_income
service_provided
[ "REIMBURSEMENT ISSUES", "PHARMACEUTICAL AND LIFE SCIENCE ISSUES" ]
[ "MMM - Medicare/Medicaid", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2010-Q1
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "JENNIFER VESEY ROSSMAN (POLICY ADVISOR, SEN. RICK SANTORUM)", "TAMAR THOMPSON", "JEFFREY J KIMBELL", "JODIE LOCKHART", "JENNIFER VESEY ROSSMAN (POLICY ADVISOR, SEN. RICK SANTORUM)", "TAMAR THOMPSON" ]
[ 42442, 51434, 39999, 51143, 42442, 51434, 39999, 51143 ]
[ null, null, "POLICY ADVISOR, SEN. RICK SANTORUM", null, null, null, "POLICY ADVISOR, SEN. RICK SANTORUM", null ]
[ false, false, false, true, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/199c696d-3501-484a-bcb1-9e7a171cd1d8/print/
199c696d-3501-484a-bcb1-9e7a171cd1d8
199c696d-3501-484a-bcb1-9e7a171cd1d8_46038_153900
astellas pharma us
2010-04-20T15:49:08
YNCHF
2010-04-20T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "H.R.3590, Patient Protection and Affordable Care Act. H.R.4872, Health Care and Education Reconciliation Act of 2010. H.R. 1458/S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Incentives for companies to develop anti-biotics/anti-infectives with FDA priority reveiw voucher. Issues pertaining to community and hospital acquired infections (HAC). 340b program. Biosimilars.", "H.R.4872, Health Care and Education Reconciliation Act of 2010; H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act. H.R. 1458/S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Issues pertaining to community and hospital acquired infections (HAC).", "S. 2753, a bill to suspend temporarily the suspension of duty on RSD 1235." ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid", "TAR - Tariff (miscellaneous tariff bills)" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2010-Q1
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JONATHON JONES", "JOHN MICHAEL GONZALEZ (Chief of Staff, Rep. Melissa Bean)", "SHEILA MURPHY (Legislative Director, Senator Klobuchar)", "SEAN RICHARDSON", "JONATHON JONES", "JOHN MICHAEL GONZALEZ (Chief of Staff, Rep. Melissa Bean)", "SHEILA MURPHY (Legislative Director, Senator Klobuchar)", "SEAN RICHARDSON", "JONATHON JONES", "JOHN MICHAEL GONZALEZ (Chief of Staff, Rep. Melissa Bean)", "SHEILA MURPHY (Legislative Director, Senator Klobuchar)", "SEAN RICHARDSON" ]
[ 26450, 47178, 41354, 6542, 26450, 47178, 41354, 6542, 26450, 47178, 41354, 6542 ]
[ null, "Chief of Staff, Rep. Melissa Bean", "Legislative Director, Senator Klobuchar", null, null, "Chief of Staff, Rep. Melissa Bean", "Legislative Director, Senator Klobuchar", null, null, "Chief of Staff, Rep. Melissa Bean", "Legislative Director, Senator Klobuchar", null ]
[ false, false, false, false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/024577e9-67b1-4f40-b045-ee86d700bc65/print/
024577e9-67b1-4f40-b045-ee86d700bc65
024577e9-67b1-4f40-b045-ee86d700bc65_20744_127151
astellas pharma us, inc.
2010-04-20T18:16:50
YNCHF
2010-07-14T00:00:00
astellas pharma us
Pharmaceutical company
30,000
lobbying_income
service_provided
[ "Issues pertaining to antimicrobial resistance; community and healthcare associated infections and organ transplantation; STARR Act", "Issues related to Medicare coverage of immunosuppresants; Medicaid payment for hospital-acquired conditions; the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (H.R. 1458/S.565); American's Affordable Health Choices Act (H.R. 300); America's Healthy Future Act of 2009; Affordable Healthcare for America Act (H.R. 3862); Patient Protection and Affordable Care Act (H.R. 3590)" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2010-Q2
2007-11-13
null
VA
US
1,662
0
0
2024-04-09T15:07:31.994474-04:00
CAPITOL HILL CONSULTING GROUP
926 Pennsylvania Ave, SE, Washington, DC, 20003, US
72,053
Government Relations Firm
TAZEEN AHMAD
35,843
+1 202-488-0101
[ "STEVEN E IRIZARRY", "BILL K BREWSTER", "STEVEN E IRIZARRY", "BILL K BREWSTER" ]
[ 38987, 11778, 38987, 11778 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/165609/
https://lda.senate.gov/api/v1/registrants/72053/
https://lda.senate.gov/filings/public/filing/89a7302b-9341-438f-aa54-428f625fc1b0/print/
89a7302b-9341-438f-aa54-428f625fc1b0
89a7302b-9341-438f-aa54-428f625fc1b0_72053_165609
astellas pharma us
2010-07-14T19:13:26
YNCHF
2010-07-14T00:00:00
astellas pharma us, inc.
null
50,000
lobbying_income
service_provided
[ "Issues related to CPT codes for Myocardial Perfusion Imaging; H. R. 4371; H. R. 1458, and S. 565, Comprehensive Immunosuppressive Drug coverage for Transplant Patients Act; H. R. 574 & S. 254, Medicare Home Infusion Therapy Coverage Act of 2009.", "H. R. 5175 and S. 3295, DISCLOSE Act; Issues pertaining to the campaign activities of certain domestic corporations.", "H. R. 2400, Strategies to Address Antimicrobial Resistance (STARR) Act; Issues pertaining to the development of new antibiotics; H. R. 3276, American Medical Isotope Production Act, 21st Century ALERT (Access to Life-Saving Early Detection, Research and Treatment) Act." ]
[ "MMM - Medicare/Medicaid", "GOV - Government Issues", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2010-Q2
2007-07-01
null
IL
US
1,002,983
0
null
2024-01-30T12:37:26.892278-05:00
ML STRATEGIES, LLC
555 12th Street NW, Suite 1100, Washington, DC, 20004, US
25,603
Government relations consulting firm
KENISHA RUSSELL
33,962
+1 202-434-7310
[ "JEREMY RABINOVITZ", "JEREMY RABINOVITZ", "JEREMY RABINOVITZ" ]
[ 31268, 31268, 31268 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/133380/
https://lda.senate.gov/api/v1/registrants/25603/
https://lda.senate.gov/filings/public/filing/c7fe2a37-4935-4d3a-8926-b81a512a515c/print/
c7fe2a37-4935-4d3a-8926-b81a512a515c
c7fe2a37-4935-4d3a-8926-b81a512a515c_25603_133380
astellas pharma us, inc.
2010-07-14T16:04:14
YNCHF
2010-07-19T00:00:00
astellas pharma us
Pharmaceutical company
60,000
lobbying_income
service_provided
[ "PHARMACEUTICAL AND LIFE SCIENCE ISSUES", "REIMBURSEMENT ISSUES" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2010-Q2
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "JENNIFER VESEY ROSSMAN (POLICY ADVISOR, SEN. RICK SANTORUM)", "TAMAR THOMPSON", "JEFFREY J KIMBELL", "JODIE LOCKHART", "JENNIFER VESEY ROSSMAN (POLICY ADVISOR, SEN. RICK SANTORUM)", "TAMAR THOMPSON" ]
[ 42442, 51434, 39999, 51143, 42442, 51434, 39999, 51143 ]
[ null, null, "POLICY ADVISOR, SEN. RICK SANTORUM", null, null, null, "POLICY ADVISOR, SEN. RICK SANTORUM", null ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/c0e06ab7-421b-424f-9f52-91283038d95b/print/
c0e06ab7-421b-424f-9f52-91283038d95b
c0e06ab7-421b-424f-9f52-91283038d95b_46038_153900
astellas pharma us
2010-07-19T22:26:37
YNCHF
2010-07-19T00:00:00
astellas pharma us, inc.
null
0
a
service_provided
[ "Issues pertaining to antimicrobial resistance (the Strategies to Address Antimicrobial Resistance Act (HR 2400)).\nIssues pertaining to community and healthcare associated infections.\nIssues pertaining to medical isotopes (the American Medical Isotopes Production Act of 2009 (HR 3276)). Issues related to 340B program, follow on biologics, hospital readmissions/bundling and home infusion therapy coverage (the Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act (HR 1458/S 565), the Patient Protection and Affordable Care Act (HR 3590), Affordable Health Care for America Act (HR 3962), and the Health Care and Education Reconciliation Act of 2010 (HR 4872)).\n\nIssues related to oncology coverage (the Comprehensive Cancer Care Improvement Act of 2009 (HR 1844)).\n\nIssues related to 340B (the American Jobs and Closing Tax Loopholes Act of 2010 (HR 4213)).", "Issues related to hospital readmissions/bundling and home infusion therapy coverage, (the Medicare Home Infusion Therapy \nCoverage Act of 2009 (HR 574/S 254))\n\nThe Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act (HR 1458/S 565) Issues related to Medicare physician payment system (to amend title XVIII of the Social Security Act to continue using 2009 Medicare practice expense relative value units for certain cardiology services, (HR 4371)), and CPT codes for myocardial perfusion imaging. \n\nThe Health Care and Education Reconciliation Act of 2010 (HR 4872), the Patient Protection and Affordable Care (HR 3590),\nand the Affordable Health Care for America Act (HR 3962).\n\nIssues related to oncology coverage and medicare clinical trials (the Comprehensive Cancer Care Improvement Act of 2009 (HR 1844)).", "Issues pertaining to campaign activities of certain domestic corporations (the DISCLOSE Act (HR 5175/S3295)).", "Tariff duty suspension for RSD 1235 (a bill to extend temporarily the suspension of duty on RSD 1235 (S 2753))." ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid", "GOV - Government Issues", "TAR - Tariff (miscellaneous tariff bills)" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2010-Q2
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA", "BRIAN CORRIGAN", "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA", "BRIAN CORRIGAN", "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA", "BRIAN CORRIGAN", "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA", "BRIAN CORRIGAN" ]
[ 40398, 40403, 51790, 40398, 40403, 51790, 40398, 40403, 51790, 40398, 40403, 51790 ]
[ null, null, null, null, null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/653c5f1a-c878-406d-a494-7d2bdc8c1d2d/print/
653c5f1a-c878-406d-a494-7d2bdc8c1d2d
653c5f1a-c878-406d-a494-7d2bdc8c1d2d_40032268_188248
astellas pharma us, inc.
2010-07-19T19:32:12
YNCHF
2010-07-20T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "H.R. 1458/S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Incentives for companies to develop anti-biotics/anti-infectives with FDA priority reveiw voucher. Issues pertaining to community and hospital acquired infections (HAC). 340b program. Biosimilars. H.R. 2400, the Strategies to Address Antimicrobial Resistance Act. H.R.4213, American Jobs and Closing Tax Loopholes Act of 2010: 340b provisions.", "H.R. 1458/S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Issues pertaining to community and hospital acquired infections (HAC).", "S. 2753, a bill to suspend temporarily the suspension of duty on RSD 1235." ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid", "TAR - Tariff (miscellaneous tariff bills)" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2010-Q2
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JONATHON JONES", "JOHN MICHAEL GONZALEZ", "SHEILA MURPHY", "SEAN RICHARDSON", "JONATHON JONES", "JOHN MICHAEL GONZALEZ", "SHEILA MURPHY", "SEAN RICHARDSON", "JONATHON JONES", "JOHN MICHAEL GONZALEZ", "SHEILA MURPHY", "SEAN RICHARDSON" ]
[ 26450, 47178, 41354, 6542, 26450, 47178, 41354, 6542, 26450, 47178, 41354, 6542 ]
[ null, null, null, null, null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/e4d58573-6f15-46b2-b662-ab769ba9f382/print/
e4d58573-6f15-46b2-b662-ab769ba9f382
e4d58573-6f15-46b2-b662-ab769ba9f382_20744_127151
astellas pharma us, inc.
2010-07-20T16:03:50
YNCHF
2010-07-20T00:00:00
astellas pharma us, inc.
Pharmaceutical manufacturing and marketing.
10,000
lobbying_income
service_provided
[ "Issues related to antibiotic development incentives." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2010-Q2
2010-06-01
null
IL
US
1,003,785
0
0
2024-01-30T20:18:32.515056-05:00
ARNOLD & PORTER KAYE SCHOLER LLP
601 Massachusetts Ave. NW, Washington, DC, 20001, US
4,301
Law firm
NICHOLAS TOWNSEND
31,381
+1 202-942-5249
[ "DANIEL A KRACOV" ]
[ 41525 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/104567/
https://lda.senate.gov/api/v1/registrants/4301/
https://lda.senate.gov/filings/public/filing/430244e6-24be-4dbc-9953-c3800655c277/print/
430244e6-24be-4dbc-9953-c3800655c277
430244e6-24be-4dbc-9953-c3800655c277_4301_104567
astellas pharma us, inc.
2010-07-20T22:35:06
YNCHF
2010-10-14T00:00:00
astellas pharma us
Pharmaceutical company
0
lobbying_income
service_provided
[ "Issues related to Medicare coverage of immunosuppressants; Medicaid payment for hospital-acquired conditions; the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (H.R. 1458/S. 565); American's Affordable Health Choices Act (H.R. 300); America's Healthy Future Act of 2009; Affordable Healthcare for America Act (H.R. 3862); Patient Protection and Affordable Health Care Act (H.R.3950)", "Issues pertaining to antimicrobial resistance; community and health care associated infections and organ transplantation; STARR Act" ]
[ "MMM - Medicare/Medicaid", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2010-Q3
2007-11-13
null
VA
US
1,662
0
0
2024-04-09T15:07:31.994474-04:00
CAPITOL HILL CONSULTING GROUP
926 Pennsylvania Ave, SE, Washington, DC, 20003, US
72,053
Government Relations Firm
TAZEEN AHMAD
35,843
+1 202-488-0101
[ "STEVEN E IRIZARRY", "BILL K BREWSTER", "STEVEN E IRIZARRY", "BILL K BREWSTER" ]
[ 38987, 11778, 38987, 11778 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/165609/
https://lda.senate.gov/api/v1/registrants/72053/
https://lda.senate.gov/filings/public/filing/36b8155f-a5a5-462c-9821-a65910009cc6/print/
36b8155f-a5a5-462c-9821-a65910009cc6
36b8155f-a5a5-462c-9821-a65910009cc6_72053_165609
astellas pharma us
2010-10-14T22:31:52
YNCHF
2010-10-18T00:00:00
astellas pharma us
Pharmaceutical company
60,000
lobbying_income
service_provided
[ "REIMBURSEMENT ISSUES", "PHARMACEUTICAL AND LIFE SCIENCE ISSUES" ]
[ "MMM - Medicare/Medicaid", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2010-Q3
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "JENNIFER VESEY ROSSMAN (POLICY ADVISOR, SEN. RICK SANTORUM)", "TAMAR THOMPSON", "JEFFREY J KIMBELL", "JODIE LOCKHART", "JENNIFER VESEY ROSSMAN (POLICY ADVISORY, SEN.RICK SANTORUM)", "TAMAR THOMPSON" ]
[ 42442, 51434, 39999, 51143, 42442, 51434, 39999, 51143 ]
[ null, null, "POLICY ADVISOR, SEN. RICK SANTORUM", null, null, null, "POLICY ADVISORY, SEN.RICK SANTORUM", null ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/0495efe0-9d22-4bb5-aae3-7764bfd4c4f1/print/
0495efe0-9d22-4bb5-aae3-7764bfd4c4f1
0495efe0-9d22-4bb5-aae3-7764bfd4c4f1_46038_153900
astellas pharma us
2010-10-18T19:09:11
YNCHF
2010-10-18T00:00:00
astellas pharma us, inc.
null
50,000
lobbying_income
service_provided
[ "H. R. 1458, and S. 565, Comprehensive Immunosuppressive Drug coverage for Transplant Patients Act.", "H. R. 5175 and S. 3295, DISCLOSE Act; Issues pertaining to the campaign activities of certain domestic corporations.", "H. R. 2400, Strategies to Address Antimicrobial Resistance (STARR) Act; H. R. 6331, GAIN Act; Issues pertaining to the development of new antibiotics; H. R. 3276, American Medical Isotope Production Act; H. R. 6224, 21st Century ALERT Act; Issues pertaining to the orphan drug exemption to the 340 (B) program; H. R. 6389, issues pertaining to prostate cancer diagnosis and treatment; Issues pertaining to overactive bladder syndrome.." ]
[ "MMM - Medicare/Medicaid", "GOV - Government Issues", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2010-Q3
2007-07-01
null
IL
US
1,002,983
0
null
2024-01-30T12:37:26.892278-05:00
ML STRATEGIES, LLC
555 12th Street NW, Suite 1100, Washington, DC, 20004, US
25,603
Government relations consulting firm
KENISHA RUSSELL
33,962
+1 202-434-7310
[ "JEREMY RABINOVITZ", "JEREMY RABINOVITZ", "JEREMY RABINOVITZ" ]
[ 31268, 31268, 31268 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/133380/
https://lda.senate.gov/api/v1/registrants/25603/
https://lda.senate.gov/filings/public/filing/b0b49a0e-8bee-43a9-ad78-8343608dfb2f/print/
b0b49a0e-8bee-43a9-ad78-8343608dfb2f
b0b49a0e-8bee-43a9-ad78-8343608dfb2f_25603_133380
astellas pharma us, inc.
2010-10-18T17:53:57
YNCHF
2010-10-19T00:00:00
astellas pharma us
Pharmaceutical company
30,000
lobbying_income
modify_service
[ "Issues related to Medicare coverage of immunosuppressants; the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (H.R. 1458/S. 565); American's Affordable Health Choices Act (H.R. 300); America's Healthy Future Act of 2009; Affordable Healthcare for America Act (H.R. 3862); Patient Protection and Affordable Health Care Act (H.R. 3950)", "Issues pertaining to antimicrobial resistance; community and health care associated infections and organ transplantation; STARR Act" ]
[ "MMM - Medicare/Medicaid", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2010-Q3
2007-11-13
null
VA
US
1,662
0
0
2024-04-09T15:07:31.994474-04:00
CAPITOL HILL CONSULTING GROUP
926 Pennsylvania Ave, SE, Washington, DC, 20003, US
72,053
Government Relations Firm
TAZEEN AHMAD
35,843
+1 202-488-0101
[ "STEVEN E IRIZARRY", "BILL K BREWSTER", "STEVEN E IRIZARRY", "BILL K BREWSTER" ]
[ 38987, 11778, 38987, 11778 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/165609/
https://lda.senate.gov/api/v1/registrants/72053/
https://lda.senate.gov/filings/public/filing/341aebab-0e11-4ec2-bc61-db2484d00cd1/print/
341aebab-0e11-4ec2-bc61-db2484d00cd1
341aebab-0e11-4ec2-bc61-db2484d00cd1_72053_165609
astellas pharma us
2010-10-19T15:01:24
YNCHF
2010-10-19T00:00:00
astellas pharma us, inc.
null
310,000
a
modify_service
[ "Tariff duty suspension for RSD 1235 (a bill to extend temporarily the suspension of duty on RSD 1235 (S 2753)).", "Issues pertaining to antimicrobial resistance (the Strategies to Address Antimicrobial Resistance Act (HR 2400)).\nIssues pertaining to community and healthcare associated infections.\nIssues pertaining to medical isotopes (the American Medical Isotopes Production Act of 2009 (HR 3276)). Issues related to 340B program, follow on biologics, hospital readmissions/bundling and home infusion therapy coverage (the Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act (HR 1458/S 565), the Patient Protection and Affordable Care Act (HR 3590), Affordable Health Care for America Act (HR 3962), and the Health Care and Education Reconciliation Act of 2010 (HR 4872)).\n\nIssues related to oncology coverage (the Comprehensive Cancer Care Improvement Act of 2009 (HR 1844)).\n\nIssues related to 340B (the American Jobs and Closing Tax Loopholes Act of 2010 (HR 4213)).", "Issues related to hospital readmissions/bundling and home infusion therapy coverage, (the Medicare Home Infusion Therapy \nCoverage Act of 2009 (HR 574/S 254))\n\nThe Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act (HR 1458/S 565) Issues related to Medicare physician payment system (to amend title XVIII of the Social Security Act to continue using 2009 Medicare practice expense relative value units for certain cardiology services, (HR 4371)), and CPT codes for myocardial perfusion imaging. \n\nThe Health Care and Education Reconciliation Act of 2010 (HR 4872), the Patient Protection and Affordable Care (HR 3590),\nand the Affordable Health Care for America Act (HR 3962).\n\nIssues related to oncology coverage and medicare clinical trials (the Comprehensive Cancer Care Improvement Act of 2009 (HR 1844)).", "Issues pertaining to campaign activities of certain domestic corporations (the DISCLOSE Act (HR 5175/S3295))." ]
[ "TAR - Tariff (miscellaneous tariff bills)", "HCR - Health Issues", "MMM - Medicare/Medicaid", "GOV - Government Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2010-Q2
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA", "BRIAN CORRIGAN", "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA", "BRIAN CORRIGAN", "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA", "BRIAN CORRIGAN", "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA", "BRIAN CORRIGAN" ]
[ 40398, 40403, 51790, 40398, 40403, 51790, 40398, 40403, 51790, 40398, 40403, 51790 ]
[ null, null, null, null, null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/e3142c65-2b8b-44b3-b5c6-8f88c29c6384/print/
e3142c65-2b8b-44b3-b5c6-8f88c29c6384
e3142c65-2b8b-44b3-b5c6-8f88c29c6384_40032268_188248
astellas pharma us, inc.
2010-10-19T16:24:48
YNCHF
2010-10-19T00:00:00
astellas pharma us, inc.
null
440,000
a
service_provided
[ "Tariff duty suspension for RSD 1235 (a bill to extend temporarily the suspension of duty on RSD 1235 (S 2753)).", "Issues pertaining to antimicrobial resistance (the Strategies to Address Antimicrobial Resistance Act (HR 2400)).\nIssues pertaining to community and healthcare associated infections. \nIssues pertaining to medical isotopes (the American Medical Isotopes Production Act of 2009 (HR 3276)). Issues related to the 340B program, follow-on biologics (the Patient Protection and Affordable Care Act (HR 3590); the Affordable Health Care for America Act (HR 3962); and the Health Care and Education Reconciliation Act of 2010 (HR 4872)).\nIssues related to oncology coverage (the Comprehensive Cancer Care Improvement Act of 2009 (HR 1844)).\nIssues related to oral cancer parity (the Cancer Drug Coverage Parity Act of 2009 (HR 2366)).\nIssues related to 340B (the American Jobs and Closing Tax Loopholes Act of 2010 (HR 4213)).\nIssues related to development incentives for infectious disease products (HR 6331)).\nIssues related to prostate cancer awareness (the PROSTATE Act of 2010 (S 3775)).", "Issues pertaining to the campaign activities of certain domestic corporations (the DISCLOSE Act (HR 5175/S 3295)).", "The Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act (HR 1458/S 565). \nThe Health Care and Education Reconciliation Act of 2010 (HR 4872); the Patient Protection and Affordable Care Act (HR 3590); and the Affordable Health Care for America Act (HR 3962). Issues related to oncology coverage and Medicare clinical trials (the Comprehensive Cancer Care Improvement Act of 2009 (HR 1844))." ]
[ "TAR - Tariff (miscellaneous tariff bills)", "HCR - Health Issues", "GOV - Government Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2010-Q3
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA", "BRIAN CORRIGAN", "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA", "BRIAN CORRIGAN", "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA", "BRIAN CORRIGAN", "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA", "BRIAN CORRIGAN" ]
[ 40398, 40403, 51790, 40398, 40403, 51790, 40398, 40403, 51790, 40398, 40403, 51790 ]
[ null, null, null, null, null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/abe6519e-5150-4664-b405-40ba07c1fce7/print/
abe6519e-5150-4664-b405-40ba07c1fce7
abe6519e-5150-4664-b405-40ba07c1fce7_40032268_188248
astellas pharma us, inc.
2010-10-19T16:28:03
YNCHF
2010-10-20T00:00:00
astellas pharma us, inc.
Pharmaceutical manufacturing and marketing.
10,000
lobbying_income
service_provided
[ "Issues related to antibiotic development incentives." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES" ]
2010-Q3
2010-06-01
null
IL
US
1,003,785
0
0
2024-01-30T20:18:32.515056-05:00
ARNOLD & PORTER KAYE SCHOLER LLP
601 Massachusetts Ave. NW, Washington, DC, 20001, US
4,301
Law firm
NICHOLAS TOWNSEND
31,381
+1 202-942-5249
[ "DANIEL A KRACOV" ]
[ 41525 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/104567/
https://lda.senate.gov/api/v1/registrants/4301/
https://lda.senate.gov/filings/public/filing/c404c1b4-aa79-46d2-b3e2-34f31c5223ea/print/
c404c1b4-aa79-46d2-b3e2-34f31c5223ea
c404c1b4-aa79-46d2-b3e2-34f31c5223ea_4301_104567
astellas pharma us, inc.
2010-10-20T18:55:19
YNCHF
2010-10-20T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "H.R. 1458/S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009. Incentives for companies to develop anti-biotics/anti-infectives. H.R. 6331, Generating Antibiotic Incentives Now Act of 2010. Issues pertaining to community and hospital acquired infections (HAC). 340b program. Biosimilars. H.R. 2400, the Strategies to Address Antimicrobial Resistance Act. H.R.4213, American Jobs and Closing Tax Loopholes Act of 2010: 340b provisions.", "H.R. 1458/S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009. Issues pertaining to community and hospital acquired infections (HAC).", "S. 2753, a bill to suspend temporarily the suspension of duty on RSD 1235." ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid", "TAR - Tariff (miscellaneous tariff bills)" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2010-Q3
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JONATHON JONES", "JOHN MICHAEL GONZALEZ", "SHEILA MURPHY", "SEAN RICHARDSON", "JONATHON JONES", "JOHN MICHAEL GONZALEZ", "SHEILA MURPHY", "SEAN RICHARDSON", "JONATHON JONES", "JOHN MICHAEL GONZALEZ", "SHEILA MURPHY", "SEAN RICHARDSON" ]
[ 26450, 47178, 41354, 6542, 26450, 47178, 41354, 6542, 26450, 47178, 41354, 6542 ]
[ null, null, null, null, null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/b5a374f0-9f9c-4e31-abad-f8e53bcd828f/print/
b5a374f0-9f9c-4e31-abad-f8e53bcd828f
b5a374f0-9f9c-4e31-abad-f8e53bcd828f_20744_127151
astellas pharma us, inc.
2010-10-20T20:04:29
YNCHF
2011-01-18T00:00:00
astellas pharma us, inc.
null
50,000
lobbying_income
service_provided
[ "H. R. 1458, and S. 565, Comprehensive Immunosuppressive Drug coverage for Transplant Patients Act; General issues pertaining to immunosupressives.", "H. R. 6517, Omnibus Trade Act of 2010, miscellaneous trade provisions.", "H. R. 2400, Strategies to Address Antimicrobial Resistance (STARR) Act; H. R. 6331, GAIN Act; Issues pertaining to the development of new antibiotics; H. R. 3276, American Medical Isotope Production Act; H. R. 6224, 21st Century ALERT Act; Issues pertaining to the orphan drug exemption to the 340 (B) program." ]
[ "MMM - Medicare/Medicaid", "TRD - Trade (domestic/foreign)", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2010-Q4
2007-07-01
null
IL
US
1,002,983
0
null
2024-01-30T12:37:26.892278-05:00
ML STRATEGIES, LLC
555 12th Street NW, Suite 1100, Washington, DC, 20004, US
25,603
Government relations consulting firm
KENISHA RUSSELL
33,962
+1 202-434-7310
[ "JEREMY RABINOVITZ", "JEREMY RABINOVITZ", "JEREMY RABINOVITZ" ]
[ 31268, 31268, 31268 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/133380/
https://lda.senate.gov/api/v1/registrants/25603/
https://lda.senate.gov/filings/public/filing/bdb942bc-5a40-4915-8e0c-001c052b6838/print/
bdb942bc-5a40-4915-8e0c-001c052b6838
bdb942bc-5a40-4915-8e0c-001c052b6838_25603_133380
astellas pharma us, inc.
2011-01-18T18:26:56
YNCHF
2011-01-19T00:00:00
astellas pharma us
Pharmaceutical company
60,000
lobbying_income
service_provided
[ "PHARMACEUTICAL AND LIFE SCIENCES ISSUES", "REIMBURSEMENT ISSUES" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2010-Q4
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "JENNIFER VESEY ROSSMAN (POLICY ADVISOR, SEN. RICK SANTORUM)", "TAMAR THOMPSON", "JEFFREY J KIMBELL", "JODIE LOCKHART", "JENNIFER VESEY ROSSMAN (Policy Advisor for Sen. Rick Santorum)", "TAMAR THOMPSON" ]
[ 42442, 51434, 39999, 51143, 42442, 51434, 39999, 51143 ]
[ null, null, "POLICY ADVISOR, SEN. RICK SANTORUM", null, null, null, "Policy Advisor for Sen. Rick Santorum", null ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/3b7eb781-1035-4778-8a23-6807e1ae11fa/print/
3b7eb781-1035-4778-8a23-6807e1ae11fa
3b7eb781-1035-4778-8a23-6807e1ae11fa_46038_153900
astellas pharma us
2011-01-19T14:58:25
YNCHF
2011-01-19T00:00:00
astellas pharma us
Pharmaceutical company
30,000
lobbying_income
service_provided
[ "Issues pertaining to antimicrobial resistance; community and health care associated infections and organ transplantation; STARR Act", "Issues related to Medicare coverage of immunosuppressants" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2010-Q4
2007-11-13
null
VA
US
1,662
0
0
2024-04-09T15:07:31.994474-04:00
CAPITOL HILL CONSULTING GROUP
926 Pennsylvania Ave, SE, Washington, DC, 20003, US
72,053
Government Relations Firm
TAZEEN AHMAD
35,843
+1 202-488-0101
[ "BILL K BREWSTER", "STEVEN E IRIZARRY", "STEVEN E IRIZARRY", "BILL K BREWSTER" ]
[ 11778, 38987, 38987, 11778 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/165609/
https://lda.senate.gov/api/v1/registrants/72053/
https://lda.senate.gov/filings/public/filing/0c5400d5-cdbb-4f5e-b9a2-1f7ecac543ba/print/
0c5400d5-cdbb-4f5e-b9a2-1f7ecac543ba
0c5400d5-cdbb-4f5e-b9a2-1f7ecac543ba_72053_165609
astellas pharma us
2011-01-19T23:52:23
YNCHF
2011-01-20T00:00:00
astellas pharma us, inc.
null
380,000
a
service_provided
[ "Issues pertaining to antimicrobial resistance (the Strategies to Address Antimicrobial Resistance Act (HR 2400)).\nIssues pertaining to community and healthcare associated infections. \nIssues pertaining to medical isotopes (the American Medical Isotopes Production Act of 2009 (HR 3276)). Issues related to the 340B program, follow-on biologics (the Patient Protection and Affordable Care Act (HR 3590); the Affordable Health Care for America Act (HR 3962); and the Health Care and Education Reconciliation Act of 2010 (HR 4872)).\nIssues related to oncology coverage (the Comprehensive Cancer Care Improvement Act of 2009 (HR 1844)).\nIssues related to oral cancer parity (the Cancer Drug Coverage Parity Act of 2009 (HR 2366)).\nIssues related to 340B (the American Jobs and Closing Tax Loopholes Act of 2010 (HR 4213)).\nIssues related to development incentives for infectious disease products (HR 6331)).\nIssues related to prostate cancer awareness (the PROSTATE Act of 2010 (S 3775)).", "The Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act (HR 1458/S 565). \nThe Health Care and Education Reconciliation Act of 2010 (HR 4872); the Patient Protection and Affordable Care Act (HR 3590); and the Affordable Health Care for America Act (HR 3962). Issues related to oncology coverage and Medicare clinical trials (the Comprehensive Cancer Care Improvement Act of 2009 (HR 1844)).", "Issues pertaining to the campaign activities of certain domestic corporations (the DISCLOSE Act (HR 5175/S 3295)).", "Tariff duty suspension for RSD 1235 (a bill to extend temporarily the suspension of duty on RSD 1235 (S 2753/HR 6517))." ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid", "GOV - Government Issues", "TAR - Tariff (miscellaneous tariff bills)" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2010-Q4
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA", "BRIAN CORRIGAN", "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA", "BRIAN CORRIGAN", "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA", "BRIAN CORRIGAN", "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA", "BRIAN CORRIGAN" ]
[ 40398, 40403, 51790, 40398, 40403, 51790, 40398, 40403, 51790, 40398, 40403, 51790 ]
[ null, null, null, null, null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/f173949b-6b29-467b-9e44-4dff3d99825c/print/
f173949b-6b29-467b-9e44-4dff3d99825c
f173949b-6b29-467b-9e44-4dff3d99825c_40032268_188248
astellas pharma us, inc.
2011-01-20T14:23:52
YNCHF
2011-01-20T00:00:00
astellas pharma us, inc.
Pharmaceutical manufacturing and marketing.
10,000
lobbying_income
service_provided
[ "Issues related to antibiotic development incentives." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES" ]
2010-Q4
2010-06-01
null
IL
US
1,003,785
0
0
2024-01-30T20:18:32.515056-05:00
ARNOLD & PORTER KAYE SCHOLER LLP
601 Massachusetts Ave. NW, Washington, DC, 20001, US
4,301
Law firm
NICHOLAS TOWNSEND
31,381
+1 202-942-5249
[ "DANIEL A KRACOV" ]
[ 41525 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/104567/
https://lda.senate.gov/api/v1/registrants/4301/
https://lda.senate.gov/filings/public/filing/00b82fc4-1b99-4dbd-973d-6c5cd999226f/print/
00b82fc4-1b99-4dbd-973d-6c5cd999226f
00b82fc4-1b99-4dbd-973d-6c5cd999226f_4301_104567
astellas pharma us, inc.
2011-01-20T19:18:24
YNCHF
2011-01-20T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "H.R. 1458/S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009. Incentives for companies to develop anti-biotics/anti-infectives. H.R. 6331, Generating Antibiotic Incentives Now Act of 2010. Issues pertaining to community and hospital acquired infections (HAC). 340b program. Biosimilars. H.R. 2400, the Strategies to Address Antimicrobial Resistance Act. H.R.4213, American Jobs and Closing Tax Loopholes Act of 2010: 340b provisions.", "H.R. 1458/S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009. Issues pertaining to community and hospital acquired infections (HAC).", "S. 2753, a bill to suspend temporarily the suspension of duty on RSD 1235." ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid", "TAR - Tariff (miscellaneous tariff bills)" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2010-Q4
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY", "SEAN RICHARDSON", "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY", "SEAN RICHARDSON", "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY", "SEAN RICHARDSON" ]
[ 47178, 26450, 41354, 6542, 47178, 26450, 41354, 6542, 47178, 26450, 41354, 6542 ]
[ null, null, null, null, null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/be4c2c93-5c94-4d2e-8b04-e141901c8f26/print/
be4c2c93-5c94-4d2e-8b04-e141901c8f26
be4c2c93-5c94-4d2e-8b04-e141901c8f26_20744_127151
astellas pharma us, inc.
2011-01-20T21:20:32
YNCHF
2011-04-14T00:00:00
astellas pharma us, inc.
null
50,000
lobbying_income
service_provided
[ "General issues pertaining to funding levels for Medicare and Medicaid.", "Issues relating to the implementation of the Affordable Health Care Act; Issues pertaining to the development of new antibiotics; S.99, American Medical Isotope Production Act; Issues pertaining to cancer research and treatment; Issues pertaining to drug safety." ]
[ "MMM - Medicare/Medicaid", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2011-Q1
2007-07-01
null
IL
US
1,002,983
0
null
2024-01-30T12:37:26.892278-05:00
ML STRATEGIES, LLC
555 12th Street NW, Suite 1100, Washington, DC, 20004, US
25,603
Government relations consulting firm
KENISHA RUSSELL
33,962
+1 202-434-7310
[ "JEREMY RABINOVITZ", "JEREMY RABINOVITZ" ]
[ 31268, 31268 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/133380/
https://lda.senate.gov/api/v1/registrants/25603/
https://lda.senate.gov/filings/public/filing/a73ec5c6-aabb-4d61-8ef1-c932664ac03a/print/
a73ec5c6-aabb-4d61-8ef1-c932664ac03a
a73ec5c6-aabb-4d61-8ef1-c932664ac03a_25603_133380
astellas pharma us, inc.
2011-04-14T13:29:05
YNCHF
2011-04-19T00:00:00
astellas pharma us
Pharmaceutical company
30,000
lobbying_income
service_provided
[ "Issues pertaining to antimicrobial resistance; community and health care associated infections and organ transplantation; Patient Protection and Affordable Care Act (P.L. 111-148); Prescription Drug User Fee Act", "General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement of pharmaceuticals" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2011-Q1
2007-11-13
null
VA
US
1,662
0
0
2024-04-09T15:07:31.994474-04:00
CAPITOL HILL CONSULTING GROUP
926 Pennsylvania Ave, SE, Washington, DC, 20003, US
72,053
Government Relations Firm
TAZEEN AHMAD
35,843
+1 202-488-0101
[ "BILL K BREWSTER", "STEVEN E IRIZARRY", "STEVEN E IRIZARRY", "BILL K BREWSTER" ]
[ 11778, 38987, 38987, 11778 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/165609/
https://lda.senate.gov/api/v1/registrants/72053/
https://lda.senate.gov/filings/public/filing/7d386820-782f-42b9-b79e-95de8e07156b/print/
7d386820-782f-42b9-b79e-95de8e07156b
7d386820-782f-42b9-b79e-95de8e07156b_72053_165609
astellas pharma us
2011-04-19T16:12:27
YNCHF
2011-04-19T00:00:00
astellas pharma us, inc.
Pharmaceutical manufacturing and marketing.
10,000
lobbying_income
service_provided
[ "Issues related to antibiotic development incentives." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES" ]
2011-Q1
2010-06-01
null
IL
US
1,003,785
0
0
2024-01-30T20:18:32.515056-05:00
ARNOLD & PORTER KAYE SCHOLER LLP
601 Massachusetts Ave. NW, Washington, DC, 20001, US
4,301
Law firm
NICHOLAS TOWNSEND
31,381
+1 202-942-5249
[ "DANIEL A KRACOV" ]
[ 41525 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/104567/
https://lda.senate.gov/api/v1/registrants/4301/
https://lda.senate.gov/filings/public/filing/c5e62aee-12b0-421a-a8e1-027074465178/print/
c5e62aee-12b0-421a-a8e1-027074465178
c5e62aee-12b0-421a-a8e1-027074465178_4301_104567
astellas pharma us, inc.
2011-04-19T18:33:59
YNCHF
2011-04-20T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152).", "Issues related to the pharmaceutical sales fee. Issues related to the renewal of the R&D tax credit.", "Issues related to S.23/H.R. 1249, America Invents Act.", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152) Issues related to the development of new antibiotics. Issues related to the supply of medical isotopes (S. 99, the American Medical Isotopes Production Act). Issues related to reauthorization of the Prescription Drug User Fee Act. Issues related to cancer research and treatment. Issues related to drug safety." ]
[ "MMM - Medicare/Medicaid", "TAX - Taxation/Internal Revenue Code", "CPT - Copyright/Patent/Trademark", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2011-Q1
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY", "SEAN RICHARDSON", "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY", "SEAN RICHARDSON", "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY", "SEAN RICHARDSON", "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY", "SEAN RICHARDSON" ]
[ 47178, 26450, 41354, 6542, 47178, 26450, 41354, 6542, 47178, 26450, 41354, 6542, 47178, 26450, 41354, 6542 ]
[ null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/e4181e9b-3fae-4194-8e5a-0024b0ad4295/print/
e4181e9b-3fae-4194-8e5a-0024b0ad4295
e4181e9b-3fae-4194-8e5a-0024b0ad4295_20744_127151
astellas pharma us, inc.
2011-04-20T17:27:53
YNCHF
2011-04-20T00:00:00
astellas pharma us, inc.
null
390,000
a
service_provided
[ "Issues related to patent reform (the America Invents Act (S.23/H.R. 1249))", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152)", "Issues related to the pharmaceutical sales fee (no specific bills)\nIssues related to the renewal of the R&D tax credit (no specific bills)", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152)\nIssues related to the development of new antibiotics (no specific bills)\nIssues related to the supply of medical isotopes (the American Medical Isotopes Production Act (S.99)) Issues related to reauthorization of the Prescription Drug User Fee Act (no specific bills)\nIssues related to cancer research and treatment (no specific bills)\nIssues related to drug safety (no specific bills)" ]
[ "CPT - Copyright/Patent/Trademark", "MMM - Medicare/Medicaid", "TAX - Taxation/Internal Revenue Code", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2011-Q1
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MICHAEL RUGGIERO", "BRIAN CORRIGAN", "MARY LACEY REUTHER", "MICHAEL RUGGIERO", "BRIAN CORRIGAN", "MARY LACEY REUTHER", "MICHAEL RUGGIERO", "BRIAN CORRIGAN", "MARY LACEY REUTHER", "MICHAEL RUGGIERO", "BRIAN CORRIGAN", "MARY LACEY REUTHER" ]
[ 40398, 51790, 54800, 40398, 51790, 54800, 40398, 51790, 54800, 40398, 51790, 54800 ]
[ null, null, null, null, null, null, null, null, null, null, null, null ]
[ false, false, true, false, false, true, false, false, true, false, false, true ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/1adb128d-953e-4a2a-87bc-10bdbe2e2f4a/print/
1adb128d-953e-4a2a-87bc-10bdbe2e2f4a
1adb128d-953e-4a2a-87bc-10bdbe2e2f4a_40032268_188248
astellas pharma us, inc.
2011-04-20T19:57:47
YNCHF
2011-07-13T00:00:00
astellas pharma us
Pharmaceutical company
30,000
lobbying_income
service_provided
[ "Issues pertaining to antimicrobial resistance; community and health care associated infections and organ transplanatation; Patient Protection and Affordable Care Act (P.L. 111-148); Prescription Drug User Fee Act", "General Medicare and Medicaid issues including, but not limited to, coverage and reimbursement of pharmaceuticals" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2011-Q2
2007-11-13
null
VA
US
1,662
0
0
2024-04-09T15:07:31.994474-04:00
CAPITOL HILL CONSULTING GROUP
926 Pennsylvania Ave, SE, Washington, DC, 20003, US
72,053
Government Relations Firm
TAZEEN AHMAD
35,843
+1 202-488-0101
[ "BILL K BREWSTER", "STEVEN E IRIZARRY", "STEVEN E IRIZARRY", "BILL K BREWSTER" ]
[ 11778, 38987, 38987, 11778 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/165609/
https://lda.senate.gov/api/v1/registrants/72053/
https://lda.senate.gov/filings/public/filing/26811ef5-4665-4728-81f9-74611211ca21/print/
26811ef5-4665-4728-81f9-74611211ca21
26811ef5-4665-4728-81f9-74611211ca21_72053_165609
astellas pharma us
2011-07-13T21:12:06
YNCHF
2011-07-15T00:00:00
astellas pharma us, inc.
null
50,000
lobbying_income
service_provided
[ "General issues pertaining to funding levels for Medicare and Medicaid.", "Issues relating to the implementation of the Affordable Health Care Act; H. R. 2182, the Generating Antibiotic Incentives Now (GAIN) Act; S.99, American Medical Isotope Production Act; Issues pertaining to cancer research and treatment; Issues pertaining to drug safety; Issues pertaining to the reauthorization of the Prescripton Drug User Free Act (PDUFA); Issues pertaining to the development of new antibiotics; General issues pertaining to Personalized Medicine." ]
[ "MMM - Medicare/Medicaid", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2011-Q2
2007-07-01
null
IL
US
1,002,983
0
null
2024-01-30T12:37:26.892278-05:00
ML STRATEGIES, LLC
555 12th Street NW, Suite 1100, Washington, DC, 20004, US
25,603
Government relations consulting firm
KENISHA RUSSELL
33,962
+1 202-434-7310
[ "JEREMY RABINOVITZ", "KEVIN MICHAEL KAPPEL", "JEREMY RABINOVITZ", "KEVIN MICHAEL KAPPEL" ]
[ 31268, 49033, 31268, 49033 ]
[ null, null, null, null ]
[ false, true, false, true ]
https://lda.senate.gov/api/v1/clients/133380/
https://lda.senate.gov/api/v1/registrants/25603/
https://lda.senate.gov/filings/public/filing/760e2f32-3526-45c5-ba84-22392bef0f10/print/
760e2f32-3526-45c5-ba84-22392bef0f10
760e2f32-3526-45c5-ba84-22392bef0f10_25603_133380
astellas pharma us, inc.
2011-07-15T16:07:16
YNCHF
2011-07-20T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "Issues related to the pharmaceutical sales fee. Issues related to the renewal of the R&D tax credit.", "Issues related to S.23/H.R. 1249, America Invents Act.", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152) Issues related to the development of new antibiotics. Issues related to the supply of medical isotopes (S. 99, the American Medical Isotopes Production Act). Issues related to reauthorization of the Prescription Drug User Fee Act. Issues related to cancer research and treatment. Issues related to drug safety.", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152)." ]
[ "TAX - Taxation/Internal Revenue Code", "CPT - Copyright/Patent/Trademark", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2011-Q2
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY", "SEAN RICHARDSON", "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY", "SEAN RICHARDSON", "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY", "SEAN RICHARDSON", "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY", "SEAN RICHARDSON" ]
[ 47178, 26450, 41354, 6542, 47178, 26450, 41354, 6542, 47178, 26450, 41354, 6542, 47178, 26450, 41354, 6542 ]
[ null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/e6288557-35c4-44b2-8b1e-abf323993697/print/
e6288557-35c4-44b2-8b1e-abf323993697
e6288557-35c4-44b2-8b1e-abf323993697_20744_127151
astellas pharma us, inc.
2011-07-20T17:02:03
YNCHF
2011-07-20T00:00:00
astellas pharma us, inc.
Pharmaceutical manufacturing and marketing.
10,000
lobbying_income
service_provided
[ "Issues related to antibiotic development incentives and drug shortage legislation." ]
[ "HCR - Health Issues" ]
null
2011-Q2
2010-06-01
null
IL
US
1,003,785
0
0
2024-01-30T20:18:32.515056-05:00
ARNOLD & PORTER KAYE SCHOLER LLP
601 Massachusetts Ave. NW, Washington, DC, 20001, US
4,301
Law firm
NICHOLAS TOWNSEND
31,381
+1 202-942-5249
[ "DANIEL A KRACOV" ]
[ 41525 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/104567/
https://lda.senate.gov/api/v1/registrants/4301/
https://lda.senate.gov/filings/public/filing/bb0bf6c7-a68e-44e0-a9e3-2e4dacbeaed7/print/
bb0bf6c7-a68e-44e0-a9e3-2e4dacbeaed7
bb0bf6c7-a68e-44e0-a9e3-2e4dacbeaed7_4301_104567
astellas pharma us, inc.
2011-07-20T21:06:19
YNCHF
2011-07-20T00:00:00
astellas pharma us, inc.
null
320,000
a
service_provided
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152).\nIssues related to the debt ceiling negotiations and Medicare Part D rebates (no specific bills).", "Issues related to patent reform (the America Invents Act (S.23/H.R. 1249))", "Issues related to the pharmaceutical sales fee and clarification of the orphan drug exemption (no specific bills)", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152)\nIssues related to the development of new antibiotics (the Generating Antibiotic Incentives Now Act (H.R. 2182)) Issues related to reauthorization of the Prescription Drug User Fee Act (no specific bills)\nIssues related to cancer research and treatment (no specific bills)\nIssues related to drug safety (no specific bills)" ]
[ "MMM - Medicare/Medicaid", "CPT - Copyright/Patent/Trademark", "TAX - Taxation/Internal Revenue Code", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2011-Q2
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MICHAEL RUGGIERO", "BRIAN CORRIGAN", "MARY LACEY REUTHER", "MICHAEL RUGGIERO", "BRIAN CORRIGAN", "MARY LACEY REUTHER", "MICHAEL RUGGIERO", "BRIAN CORRIGAN", "MARY LACEY REUTHER", "MICHAEL RUGGIERO", "BRIAN CORRIGAN", "MARY LACEY REUTHER" ]
[ 40398, 51790, 54800, 40398, 51790, 54800, 40398, 51790, 54800, 40398, 51790, 54800 ]
[ null, null, null, null, null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/cf09adb5-cf01-42d9-8f0d-3311977cdb19/print/
cf09adb5-cf01-42d9-8f0d-3311977cdb19
cf09adb5-cf01-42d9-8f0d-3311977cdb19_40032268_188248
astellas pharma us, inc.
2011-07-20T21:48:19
YNCHF
2011-09-27T00:00:00
astellas pharma us
Pharmaceutical company
60,000
lobbying_income
service_provided
[ "PHARMACEUTICAL AND LIFE SCIENCE ISSUES", "REIMBURSEMENT ISSUES" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2011-Q2
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "TAMAR THOMPSON", "JOHN HERZOG (Health Aide, Sen. Lamar Alexander)", "JEFFREY J KIMBELL", "JODIE LOCKHART", "JOHN HERZOG (Health Aide, Sen. Lamar Alexander)", "TAMAR THOMPSON" ]
[ 42442, 51434, 51143, 53650, 42442, 51434, 53650, 51143 ]
[ null, null, null, "Health Aide, Sen. Lamar Alexander", null, null, "Health Aide, Sen. Lamar Alexander", null ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/ac4c7472-285d-4cc7-bd27-ba4f00d429c3/print/
ac4c7472-285d-4cc7-bd27-ba4f00d429c3
ac4c7472-285d-4cc7-bd27-ba4f00d429c3_46038_153900
astellas pharma us
2011-09-27T18:50:30
YNCHF
2011-10-05T00:00:00
astellas pharma us
Pharmaceutical company
30,000
lobbying_income
terminate
[ "Issues pertaining to antimicrobial resistance; community and health care associated infections and organ transplanation; Patient Protection and Affordable Care Act (P.L. 111-148); Prescription Drug User Fee Act" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2011-Q3
2007-11-13
2011-09-23
VA
US
1,662
0
0
2024-04-09T15:07:31.994474-04:00
CAPITOL HILL CONSULTING GROUP
926 Pennsylvania Ave, SE, Washington, DC, 20003, US
72,053
Government Relations Firm
TAZEEN AHMAD
35,843
+1 202-488-0101
[ "BILL K BREWSTER", "STEVEN E IRIZARRY" ]
[ 11778, 38987 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/165609/
https://lda.senate.gov/api/v1/registrants/72053/
https://lda.senate.gov/filings/public/filing/a780b8b6-50b9-4ea1-b79f-10de0626ec30/print/
a780b8b6-50b9-4ea1-b79f-10de0626ec30
a780b8b6-50b9-4ea1-b79f-10de0626ec30_72053_165609
astellas pharma us
2011-10-05T18:54:53
YNCHF
2011-10-19T00:00:00
astellas pharma us
Pharmaceutical company
60,000
lobbying_income
service_provided
[ "PHARMACEUTICAL AND LIFE SCIENCE ISSUES", "REIMBURSEMENT ISSUES" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2011-Q3
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "TAMAR THOMPSON", "JOHN HERZOG (HEALTH AIDE, SEN. LAMAR ALEXANDER)", "JEFFREY J KIMBELL", "JODIE LOCKHART", "TAMAR THOMPSON", "JOHN HERZOG (HEALTH AIDE, SEN. LAMAR ALEXANDER)" ]
[ 42442, 51434, 51143, 53650, 42442, 51434, 51143, 53650 ]
[ null, null, null, "HEALTH AIDE, SEN. LAMAR ALEXANDER", null, null, null, "HEALTH AIDE, SEN. LAMAR ALEXANDER" ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/d0879c35-caea-45ba-843b-30e4924331e1/print/
d0879c35-caea-45ba-843b-30e4924331e1
d0879c35-caea-45ba-843b-30e4924331e1_46038_153900
astellas pharma us
2011-10-19T19:33:39
YNCHF
2011-10-19T00:00:00
astellas pharma us, inc.
null
50,000
lobbying_income
service_provided
[ "Issues relating to the implementation of the Affordable Health Care Act; H. R. 2182, the Generating Antibiotic Incentives Now (GAIN) Act; S.99, American Medical Isotope Production Act; Issues pertaining to cancer research and treatment; Issues pertaining to drug safety; Issues pertaining to the reauthorization of the Prescripton Drug User Free Act (PDUFA); Issues pertaining to the development of new antibiotics.", "General issues pertaining to funding levels for Medicare and Medicaid." ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2011-Q3
2007-07-01
null
IL
US
1,002,983
0
null
2024-01-30T12:37:26.892278-05:00
ML STRATEGIES, LLC
555 12th Street NW, Suite 1100, Washington, DC, 20004, US
25,603
Government relations consulting firm
KENISHA RUSSELL
33,962
+1 202-434-7310
[ "JEREMY RABINOVITZ", "KEVIN MICHAEL KAPPEL", "JEREMY RABINOVITZ", "KEVIN MICHAEL KAPPEL" ]
[ 31268, 49033, 31268, 49033 ]
[ null, null, null, null ]
[ false, true, false, true ]
https://lda.senate.gov/api/v1/clients/133380/
https://lda.senate.gov/api/v1/registrants/25603/
https://lda.senate.gov/filings/public/filing/2b15e38a-7591-47c6-966c-c40f58e0b044/print/
2b15e38a-7591-47c6-966c-c40f58e0b044
2b15e38a-7591-47c6-966c-c40f58e0b044_25603_133380
astellas pharma us, inc.
2011-10-19T14:57:00
YNCHF
2011-10-20T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "Issues related to the pharmaceutical sales fee for Medicare Part B. Issues related to the renewal of the R&D tax credit.", "Issues related to S.23/H.R. 1249, America Invents Act.", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152) Issues related to the development of new antibiotics. Issues related to the supply of medical isotopes (S. 99, the American Medical Isotopes Production Act). Issues related to reauthorization of the Prescription Drug User Fee Act. Issues related to cancer research and treatment. Issues related to drug safety.", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152)." ]
[ "TAX - Taxation/Internal Revenue Code", "CPT - Copyright/Patent/Trademark", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2011-Q3
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY", "SEAN RICHARDSON", "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY", "SEAN RICHARDSON", "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY", "SEAN RICHARDSON", "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY", "SEAN RICHARDSON" ]
[ 47178, 26450, 41354, 6542, 47178, 26450, 41354, 6542, 47178, 26450, 41354, 6542, 47178, 26450, 41354, 6542 ]
[ null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/101ef27d-b6f8-40b1-b9f8-38ddca0682cc/print/
101ef27d-b6f8-40b1-b9f8-38ddca0682cc
101ef27d-b6f8-40b1-b9f8-38ddca0682cc_20744_127151
astellas pharma us, inc.
2011-10-20T16:13:39
YNCHF
2011-10-20T00:00:00
astellas pharma us, inc.
Pharmaceutical manufacturing and marketing.
10,000
lobbying_income
service_provided
[ "Issues related to antibiotic development incentives and drug shortage legislation." ]
[ "HCR - Health Issues" ]
null
2011-Q3
2010-06-01
null
IL
US
1,003,785
0
0
2024-01-30T20:18:32.515056-05:00
ARNOLD & PORTER KAYE SCHOLER LLP
601 Massachusetts Ave. NW, Washington, DC, 20001, US
4,301
Law firm
NICHOLAS TOWNSEND
31,381
+1 202-942-5249
[ "DANIEL A KRACOV" ]
[ 41525 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/104567/
https://lda.senate.gov/api/v1/registrants/4301/
https://lda.senate.gov/filings/public/filing/2a28e15f-704b-4dd4-82d4-bb8f7f0d9603/print/
2a28e15f-704b-4dd4-82d4-bb8f7f0d9603
2a28e15f-704b-4dd4-82d4-bb8f7f0d9603_4301_104567
astellas pharma us, inc.
2011-10-20T16:40:37
YNCHF
2011-10-20T00:00:00
astellas pharma us, inc.
null
0
a
service_provided
[ "Issues related to patent reform (the America Invents Act (S.23/H.R. 1249))", "Issues related to the pharmaceutical sales fee and clarification of the orphan drug exemption (no specific bills)", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152)\nIssues related to the development of new antibiotics (the Generating Antibiotic Incentives Now Act (H.R. 2182)) Issues related to reauthorization of the Prescription Drug User Fee Act (no specific bills)\nIssues related to cancer research and treatment (no specific bills)\nIssues related to drug safety (no specific bills)", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152).\nIssues related to the debt ceiling negotiations and Medicare Part D rebates (no specific bills)." ]
[ "CPT - Copyright/Patent/Trademark", "TAX - Taxation/Internal Revenue Code", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2011-Q3
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MICHAEL RUGGIERO", "BRIAN CORRIGAN", "MARY LACEY REUTHER", "MICHAEL RUGGIERO", "BRIAN CORRIGAN", "MARY LACEY REUTHER", "MICHAEL RUGGIERO", "BRIAN CORRIGAN", "MARY LACEY REUTHER", "MICHAEL RUGGIERO", "BRIAN CORRIGAN", "MARY LACEY REUTHER" ]
[ 40398, 51790, 54800, 40398, 51790, 54800, 40398, 51790, 54800, 40398, 51790, 54800 ]
[ null, null, null, null, null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/01e98eff-5737-40e3-ad89-56f7b0af0e7f/print/
01e98eff-5737-40e3-ad89-56f7b0af0e7f
01e98eff-5737-40e3-ad89-56f7b0af0e7f_40032268_188248
astellas pharma us, inc.
2011-10-20T22:34:37
YNCHF
2012-01-01T00:00:00
astellas pharma us, inc.
pharmaceutical company
50,000
lobbying_income
service_provided
[ "- The Federal, Food, Drug and Cosmetic Act\n- The Food and Drug Administration Safety and Innovation Act (FDASIA)\n- Bayh-Dole Act/ march in authority", "- CMMI Part B Drug Payment Demonstration Program\n- General reimbursement issues\n- H.R. 1178- Ensuring Equal Access to Treatments Act- all provisions" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2016-Q4
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY" ]
[ 64580, 56477, 64580, 56477 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/df0033da-868a-4306-9cdd-94771bd20c5a/print/
df0033da-868a-4306-9cdd-94771bd20c5a
df0033da-868a-4306-9cdd-94771bd20c5a_400762305_195037
astellas pharma us, inc.
null
YNCHF
2012-01-20T00:00:00
astellas pharma us
Pharmaceutical company
60,000
lobbying_income
service_provided
[ "PHARMACEUTICAL AND LIFE SCIENCE ISSUES", "REIMBURSEMENT ISSUES" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2011-Q4
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "TAMAR THOMPSON", "JOHN HERZOG (HEALTH AIDE SEN. LAMAR ALEXANDER)", "JEFFREY J KIMBELL", "JODIE LOCKHART", "TAMAR THOMPSON", "JOHN HERZOG (HEALTH AIDE, SEN. LAMAR ALEXANDER)" ]
[ 42442, 51434, 51143, 53650, 42442, 51434, 51143, 53650 ]
[ null, null, null, "HEALTH AIDE SEN. LAMAR ALEXANDER", null, null, null, "HEALTH AIDE, SEN. LAMAR ALEXANDER" ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/877f9d26-1444-4344-8328-f5da3c7a9879/print/
877f9d26-1444-4344-8328-f5da3c7a9879
877f9d26-1444-4344-8328-f5da3c7a9879_46038_153900
astellas pharma us
2012-01-20T19:25:10
YNCHF
2012-01-20T00:00:00
astellas pharma us, inc.
null
410,000
a
modify_service
[ "Issues related to patent reform (the America Invents Act (S.23/H.R. 1249))", "Issues related to the pharmaceutical sales fee and clarification of the orphan drug exemption (no specific bills)", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152)\nIssues related to the development of new antibiotics (the Generating Antibiotic Incentives Now Act (H.R. 2182)) Issues related to reauthorization of the Prescription Drug User Fee Act (no specific bills)\nIssues related to cancer research and treatment (no specific bills)\nIssues related to drug safety (no specific bills)", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152).\nIssues related to the debt ceiling negotiations and Medicare Part D rebates (no specific bills)." ]
[ "CPT - Copyright/Patent/Trademark", "TAX - Taxation/Internal Revenue Code", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2011-Q3
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MICHAEL RUGGIERO", "BRIAN CORRIGAN", "MARY LACEY REUTHER", "MICHAEL RUGGIERO", "BRIAN CORRIGAN", "MARY LACEY REUTHER", "MICHAEL RUGGIERO", "BRIAN CORRIGAN", "MARY LACEY REUTHER", "MICHAEL RUGGIERO", "BRIAN CORRIGAN", "MARY LACEY REUTHER" ]
[ 40398, 51790, 54800, 40398, 51790, 54800, 40398, 51790, 54800, 40398, 51790, 54800 ]
[ null, null, null, null, null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/51c9ce80-c964-4a4a-8a15-03f7e644cb12/print/
51c9ce80-c964-4a4a-8a15-03f7e644cb12
51c9ce80-c964-4a4a-8a15-03f7e644cb12_40032268_188248
astellas pharma us, inc.
2012-01-20T17:19:20
YNCHF
2012-01-20T00:00:00
astellas pharma us, inc.
null
290,000
a
service_provided
[ "Issues related to the pharmaceutical sales fee and clarification of the orphan drug exemption (no specific bills)", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152)\nIssues related to the development of new antibiotics (the Generating Antibiotic Incentives Now Act (H.R. 2182/S.1734))\nIssues related to reauthorization of the Prescription Drug User Fee Act (no specific bills) Issues related to drug shortages (Preserving Access to Life-Saving Medications Act of 2011 (H.R.2245) and Preserving Access to Life-Saving Medications Act (S.296) )", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152).\nIssues related to the debt ceiling negotiations and Medicare Part D rebates (no specific bills)." ]
[ "TAX - Taxation/Internal Revenue Code", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2011-Q4
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MICHAEL RUGGIERO", "RYAN AMBROSE (House Committee on Energy & Commerce, Clerk)", "MARY LACEY REUTHER", "MICHAEL RUGGIERO", "RYAN AMBROSE (House Committee on Energy & Commerce, Clerk)", "MARY LACEY REUTHER", "MICHAEL RUGGIERO", "RYAN AMBROSE (House Committee on Energy & Commerce, Clerk)", "MARY LACEY REUTHER" ]
[ 40398, 55562, 54800, 40398, 55562, 54800, 40398, 55562, 54800 ]
[ null, "House Committee on Energy & Commerce, Clerk", null, null, "House Committee on Energy & Commerce, Clerk", null, null, "House Committee on Energy & Commerce, Clerk", null ]
[ false, true, false, false, true, false, false, true, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/8a0e8127-9319-413c-ad8e-04ad8740d8ed/print/
8a0e8127-9319-413c-ad8e-04ad8740d8ed
8a0e8127-9319-413c-ad8e-04ad8740d8ed_40032268_188248
astellas pharma us, inc.
2012-01-20T17:22:43
YNCHF
2012-01-20T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "Issues related to the pharmaceutical sales fee for Medicare Part B. Issues related to the renewal of the R&D tax credit.", "Issues related to S.23/H.R. 1249, America Invents Act.", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152) Issues related to the development of new antibiotics. Issues related to the supply of medical isotopes (S. 99, the American Medical Isotopes Production Act). Issues related to reauthorization of the Prescription Drug User Fee Act. Issues related to cancer research and treatment. Issues related to drug safety.", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152)." ]
[ "TAX - Taxation/Internal Revenue Code", "CPT - Copyright/Patent/Trademark", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2011-Q4
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY", "SEAN RICHARDSON", "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY", "SEAN RICHARDSON", "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY", "SEAN RICHARDSON", "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY", "SEAN RICHARDSON" ]
[ 47178, 26450, 41354, 6542, 47178, 26450, 41354, 6542, 47178, 26450, 41354, 6542, 47178, 26450, 41354, 6542 ]
[ null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/c6d49686-6d2d-4a7a-8517-539c63b41d0a/print/
c6d49686-6d2d-4a7a-8517-539c63b41d0a
c6d49686-6d2d-4a7a-8517-539c63b41d0a_20744_127151
astellas pharma us, inc.
2012-01-20T19:30:54
YNCHF
2012-01-20T00:00:00
astellas pharma us, inc.
Pharmaceutical manufacturing and marketing.
5,000
lobbying_income
terminate_retainer
[]
null
null
2011-Q4
2010-06-01
2011-10-01
IL
US
1,003,785
0
0
2024-01-30T20:18:32.515056-05:00
ARNOLD & PORTER KAYE SCHOLER LLP
601 Massachusetts Ave. NW, Washington, DC, 20001, US
4,301
Law firm
NICHOLAS TOWNSEND
31,381
+1 202-942-5249
null
null
null
null
https://lda.senate.gov/api/v1/clients/104567/
https://lda.senate.gov/api/v1/registrants/4301/
https://lda.senate.gov/filings/public/filing/902e9ef5-f975-4d07-bd2b-5f76fc685614/print/
902e9ef5-f975-4d07-bd2b-5f76fc685614
902e9ef5-f975-4d07-bd2b-5f76fc685614_4301_104567
astellas pharma us, inc.
2012-01-20T21:20:21
YNCHF
2012-04-18T00:00:00
astellas pharma us, inc.
null
50,000
lobbying_income
service_provided
[ "Issues relating to the implementation of the Affordable Health Care Act; H. R. 2182 and S. 1734, the Generating Antibiotic Incentives Now (GAIN) Act; Issues pertaining to cancer research and treatment; Issues pertaining to drug safety and drug shortages; Issues pertaining to the reauthorization of the Prescripton Drug User Free Act (PDUFA); Issues pertaining to the development of new antibiotics.", "General issues pertaining to funding levels for Medicare and Medicaid." ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2012-Q1
2007-07-01
null
IL
US
1,002,983
0
null
2024-01-30T12:37:26.892278-05:00
ML STRATEGIES, LLC
555 12th Street NW, Suite 1100, Washington, DC, 20004, US
25,603
Government relations consulting firm
KENISHA RUSSELL
33,962
+1 202-434-7310
[ "JEREMY RABINOVITZ", "KEVIN MICHAEL KAPPEL", "JEREMY RABINOVITZ", "KEVIN MICHAEL KAPPEL" ]
[ 31268, 49033, 31268, 49033 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/133380/
https://lda.senate.gov/api/v1/registrants/25603/
https://lda.senate.gov/filings/public/filing/ac7aa8a3-bf01-42c9-a72c-09aa9152e42f/print/
ac7aa8a3-bf01-42c9-a72c-09aa9152e42f
ac7aa8a3-bf01-42c9-a72c-09aa9152e42f_25603_133380
astellas pharma us, inc.
2012-04-18T16:18:05
YNCHF
2012-04-19T00:00:00
astellas pharma us, inc.
pharmaceutical company
30,000
lobbying_income
service_provided
[ "The Federal, Food, Drug and Cosmetic Act\nThe Prescription Drug User Fee Act (PDUFA)\nGenerating Antibiotic Incentives Now (GAIN) Act\nPatient Protection and Affordable Care Act", "The Federal, Food, Drug and Cosmetic Act\nThe Prescription Drug User Fee Act (PDUFA)\nGenerating Antibiotic Incentives Now (GAIN) Act\nPatient Protection and Affordable Care Act" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2012-Q1
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "RICHARD CHARLES WHITE (Legislative Coordinator, Sen. John Charles)", "STEVEN E IRIZARRY (Counsel, Senate HELP and Sen. Chuck Hagel)", "RICHARD CHARLES WHITE (Legislative Coordinator, Sen. John Charles)", "STEVEN E IRIZARRY (Counsel, Senate HELP and Sen. Chuck Hagel)" ]
[ 54777, 56477, 54777, 56477 ]
[ "Legislative Coordinator, Sen. John Charles", "Counsel, Senate HELP and Sen. Chuck Hagel", "Legislative Coordinator, Sen. John Charles", "Counsel, Senate HELP and Sen. Chuck Hagel" ]
[ true, true, true, true ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/faddb37b-5f00-49e9-9f4d-95d28245845a/print/
faddb37b-5f00-49e9-9f4d-95d28245845a
faddb37b-5f00-49e9-9f4d-95d28245845a_400762305_195037
astellas pharma us, inc.
2012-04-19T20:23:07
YNCHF
2012-04-20T00:00:00
astellas pharma us
Pharmaceutical company
75,000
lobbying_income
service_provided
[ "REIMBURSEMENT ISSUES", "PHARMACEUTICAL AND LIFE SCIENCE ISSUES" ]
[ "MMM - Medicare/Medicaid", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2012-Q1
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "TAMAR THOMPSON", "JOHN HERZOG (HEALTH AIDE, SEN. LAMAR ALEXANDER)", "JEFFREY J KIMBELL", "JODIE LOCKHART", "TAMAR THOMPSON", "JOHN HERZOG (HEALTH AIDE, SEN. LAMAR ALEXANDER)" ]
[ 42442, 51434, 51143, 53650, 42442, 51434, 51143, 53650 ]
[ null, null, null, "HEALTH AIDE, SEN. LAMAR ALEXANDER", null, null, null, "HEALTH AIDE, SEN. LAMAR ALEXANDER" ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/8fa7d96b-5935-4c86-a6a1-93f01405f551/print/
8fa7d96b-5935-4c86-a6a1-93f01405f551
8fa7d96b-5935-4c86-a6a1-93f01405f551_46038_153900
astellas pharma us
2012-04-20T16:19:05
YNCHF
2012-04-20T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "Issues related to S.23/H.R. 1249, America Invents Act.", "Issues related to the pharmaceutical sales fee for Medicare Part B. Issues related to the renewal of the R&D tax credit.", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152) Issues related to the development of new antibiotics. Issues related to the supply of medical isotopes (S. 99, the American Medical Isotopes Production Act). Issues related to reauthorization of the Prescription Drug User Fee Act. Issues related to cancer research and treatment. Issues related to drug safety. S. 1734, Generating Antibiotic Incentives Now Act of 2011.", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152)." ]
[ "CPT - Copyright/Patent/Trademark", "TAX - Taxation/Internal Revenue Code", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2012-Q1
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY", "SEAN RICHARDSON", "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY", "SEAN RICHARDSON", "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY", "SEAN RICHARDSON", "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY", "SEAN RICHARDSON" ]
[ 47178, 26450, 41354, 6542, 47178, 26450, 41354, 6542, 47178, 26450, 41354, 6542, 47178, 26450, 41354, 6542 ]
[ null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/a0134697-f2ed-407f-8199-fd6b74247277/print/
a0134697-f2ed-407f-8199-fd6b74247277
a0134697-f2ed-407f-8199-fd6b74247277_20744_127151
astellas pharma us, inc.
2012-04-20T21:23:06
YNCHF
2012-04-20T00:00:00
astellas pharma us, inc.
null
680,000
a
service_provided
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152)\nIssues related to the development of new antibiotics (the Generating Antibiotic Incentives Now Act (H.R. 2182) (S.1734))\nIssues related to reauthorization of the Prescription Drug User Fee Act (no specific bills) Issues related to drug shortages (Preserving Access to Life-Saving Medications Act of 2011 (H.R.2245) and Preserving Access to Life-Saving Medications Act (S.296) ); Drug Shortages Prevention Act of 2012 (H.R. 3839))", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152).\nIssues related to the debt ceiling negotiations and Medicare Part D rebates (no specific bills)." ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2012-Q1
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MICHAEL RUGGIERO", "RYAN AMBROSE (House Committee on Energy & Commerce, Clerk)", "MARY LACEY REUTHER", "MICHAEL RUGGIERO", "RYAN AMBROSE (House Committee on Energy & Commerce, Clerk)", "MARY LACEY REUTHER" ]
[ 40398, 55562, 54800, 40398, 55562, 54800 ]
[ null, "House Committee on Energy & Commerce, Clerk", null, null, "House Committee on Energy & Commerce, Clerk", null ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/06d55670-a419-463d-b23c-109d7701b7dd/print/
06d55670-a419-463d-b23c-109d7701b7dd
06d55670-a419-463d-b23c-109d7701b7dd_40032268_188248
astellas pharma us, inc.
2012-04-21T00:40:36
YNCHF
2012-06-04T00:00:00
astellas pharma us
Pharmaceutical company
60,000
lobbying_income
service_provided
[ "REIMBURSEMENT ISSUES", "PHARMACEUTICAL AND LIFE SCIENCE ISSUES" ]
[ "MMM - Medicare/Medicaid", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2011-Q1
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "TAMAR THOMPSON", "JOHN HERZOG (Health Policy Aide, Senator Lamar Alexander)", "JENNIFER VESEY ROSSMAN (POLICY ADVISOR, SEN. RICK SANTORUM)", "JENNIFER VESEY ROSSMAN (POLICY ADVISOR, SEN. RICK SANTORUM)", "JEFFREY J KIMBELL", "JODIE LOCKHART", "TAMAR THOMPSON", "JOHN HERZOG (Health Policy Aide, Sen. Lamar Alexander)" ]
[ 42442, 51434, 51143, 53650, 39999, 39999, 42442, 51434, 51143, 53650 ]
[ null, null, null, "Health Policy Aide, Senator Lamar Alexander", "POLICY ADVISOR, SEN. RICK SANTORUM", "POLICY ADVISOR, SEN. RICK SANTORUM", null, null, null, "Health Policy Aide, Sen. Lamar Alexander" ]
[ false, false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/f6e1275d-f482-4126-9028-594878aab80b/print/
f6e1275d-f482-4126-9028-594878aab80b
f6e1275d-f482-4126-9028-594878aab80b_46038_153900
astellas pharma us
2012-06-04T20:05:44
YNCHF
2012-07-18T00:00:00
astellas pharma us
Pharmaceutical company
75,000
lobbying_income
service_provided
[ "PHARMACEUTICAL AND LIFE SCIENCE ISSUES", "REIMBURSEMENT ISSUES" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2012-Q2
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "JOHN HERZOG (HEALTH AIDE, SEN. LAMAR ALEXANDER)", "JEFFREY J KIMBELL", "JODIE LOCKHART", "JOHN HERZOG (HEALTH AIDE, SEN. LAMAR ALEXANDER)" ]
[ 42442, 51434, 53650, 42442, 51434, 53650 ]
[ null, null, "HEALTH AIDE, SEN. LAMAR ALEXANDER", null, null, "HEALTH AIDE, SEN. LAMAR ALEXANDER" ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/8760a3db-b339-47fa-bea2-8a2a45b11e7f/print/
8760a3db-b339-47fa-bea2-8a2a45b11e7f
8760a3db-b339-47fa-bea2-8a2a45b11e7f_46038_153900
astellas pharma us
2012-07-18T19:38:15
YNCHF
2012-07-18T00:00:00
astellas pharma us, inc.
null
50,000
lobbying_income
service_provided
[ "Issues relating to the implementation of the Affordable Health Care Act; H. R. 5651, Food and Drug Administration Reform Act and S. 3187, Food and Drug Administration Safety and Innovation Act, Title VIII, Generating Antibiotic Incentives Now; H. R. 2182 and S. 1734, the Generating Antibiotic Incentives Now (GAIN) Act; Issues related to drug safety and drug shortages." ]
[ "HCR - Health Issues" ]
[ "34 - Health & Human Services, Dept of (HHS)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2012-Q2
2007-07-01
null
IL
US
1,002,983
0
null
2024-01-30T12:37:26.892278-05:00
ML STRATEGIES, LLC
555 12th Street NW, Suite 1100, Washington, DC, 20004, US
25,603
Government relations consulting firm
KENISHA RUSSELL
33,962
+1 202-434-7310
[ "JEREMY RABINOVITZ", "KEVIN MICHAEL KAPPEL" ]
[ 31268, 49033 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/133380/
https://lda.senate.gov/api/v1/registrants/25603/
https://lda.senate.gov/filings/public/filing/4e021fcb-db37-427a-8138-199fe210ba41/print/
4e021fcb-db37-427a-8138-199fe210ba41
4e021fcb-db37-427a-8138-199fe210ba41_25603_133380
astellas pharma us, inc.
2012-07-18T13:30:39
YNCHF
2012-07-20T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152) Issues related to the development of new antibiotics. Issues related to drug safety. S. 1734, Generating Antibiotic Incentives Now Act of 2011. S. 3187, the Food and Drug Administration Safety and Innovation Act, now Public Law No: 112-144.", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152)." ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2012-Q2
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY", "SEAN RICHARDSON", "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY", "SEAN RICHARDSON" ]
[ 47178, 26450, 41354, 6542, 47178, 26450, 41354, 6542 ]
[ null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/29b12c14-c437-48aa-8271-14eccd5c5d82/print/
29b12c14-c437-48aa-8271-14eccd5c5d82
29b12c14-c437-48aa-8271-14eccd5c5d82_20744_127151
astellas pharma us, inc.
2012-07-20T15:54:16
YNCHF
2012-07-20T00:00:00
astellas pharma us, inc.
null
580,000
a
service_provided
[ "Issues related to the Tariff bills (H.R. 5345; H.R. 5357; H.R. 5358; H.R. 5359; H.R. 5364).", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152)\nIssues related to the development of new antibiotics (the Generating Antibiotic Incentives Now Act (H.R. 2182) (S.1734))\nIssues related to reauthorization of the Prescription Drug User Fee Act (S.3187)", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152).\nIssues related to Medicare covering immunosuppressants for ESRD patients post transplant (H.R. 2969)." ]
[ "TAX - Taxation/Internal Revenue Code", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2012-Q2
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MICHAEL RUGGIERO", "RYAN AMBROSE (House Committee on Energy & Commerce, Clerk)", "MARY LACEY REUTHER", "MICHAEL RUGGIERO", "RYAN AMBROSE (House Committee on Energy & Commerce, Clerk)", "MARY LACEY REUTHER", "MICHAEL RUGGIERO", "RYAN AMBROSE (House Committee on Energy & Commerce, Clerk)", "MARY LACEY REUTHER" ]
[ 40398, 55562, 54800, 40398, 55562, 54800, 40398, 55562, 54800 ]
[ null, "House Committee on Energy & Commerce, Clerk", null, null, "House Committee on Energy & Commerce, Clerk", null, null, "House Committee on Energy & Commerce, Clerk", null ]
[ false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/4bf65f47-aa0f-45f6-9222-160b91927c6b/print/
4bf65f47-aa0f-45f6-9222-160b91927c6b
4bf65f47-aa0f-45f6-9222-160b91927c6b_40032268_188248
astellas pharma us, inc.
2012-07-20T20:19:57
YNCHF
2012-07-20T00:00:00
astellas pharma us, inc.
pharmaceutical company
30,000
lobbying_income
service_provided
[ "The Federal, Food, Drug and Cosmetic Act\nThe Prescription Drug User Fee Act (PDUFA)\nGenerating Antibiotic Incentives Now (GAIN) Act\nPatient Protection and Affordable Care Act", "The Federal, Food, Drug and Cosmetic Act\nThe Prescription Drug User Fee Act (PDUFA)\nGenerating Antibiotic Incentives Now (GAIN) Act\nPatient Protection and Affordable Care Act" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2012-Q2
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "RICHARD CHARLES WHITE (Legislative Coordinator, Sen. John Charles)", "STEVEN E IRIZARRY (Counsel, Senate HELP and Sen. Chuck Hagel)", "RICHARD CHARLES WHITE (Legislative Coordinator, Sen. John Charles)", "STEVEN E IRIZARRY (Counsel, Senate HELP and Sen. Chuck Hagel)" ]
[ 54777, 56477, 54777, 56477 ]
[ "Legislative Coordinator, Sen. John Charles", "Counsel, Senate HELP and Sen. Chuck Hagel", "Legislative Coordinator, Sen. John Charles", "Counsel, Senate HELP and Sen. Chuck Hagel" ]
[ true, true, true, true ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/a1f658f8-1dab-492c-90aa-c5117d79004c/print/
a1f658f8-1dab-492c-90aa-c5117d79004c
a1f658f8-1dab-492c-90aa-c5117d79004c_400762305_195037
astellas pharma us, inc.
2012-07-21T02:15:50
YNCHF
2012-10-17T00:00:00
astellas pharma us
Pharmaceutical company
75,000
lobbying_income
service_provided
[ "PHARMACEUTICAL AND LIFE SCIENCES ISSUES", "REIMBURSEMENT ISSUES" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2012-Q3
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "JOHN HERZOG (HEALTH AIDE, SEN. LAMAR ALEXANDER)", "JEFFREY J KIMBELL", "JODIE LOCKHART", "JOHN HERZOG (HEALTH AIDE, SEN. LAMAR ALEXANDER)" ]
[ 42442, 51434, 53650, 42442, 51434, 53650 ]
[ null, null, "HEALTH AIDE, SEN. LAMAR ALEXANDER", null, null, "HEALTH AIDE, SEN. LAMAR ALEXANDER" ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/21073975-d633-415c-a61e-0ea8477db9b4/print/
21073975-d633-415c-a61e-0ea8477db9b4
21073975-d633-415c-a61e-0ea8477db9b4_46038_153900
astellas pharma us
2012-10-17T18:22:50
YNCHF
2012-10-18T00:00:00
astellas pharma us, inc.
null
50,000
lobbying_income
service_provided
[ "Issues relating to the implementation of the Affordable Health Care Act; S. 3187, Food and Drug Administration Safety and Innovation Act, Title VIII, Generating Antibiotic Incentives Now; Issues related to drug safety and drug shortages." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2012-Q3
2007-07-01
null
IL
US
1,002,983
0
null
2024-01-30T12:37:26.892278-05:00
ML STRATEGIES, LLC
555 12th Street NW, Suite 1100, Washington, DC, 20004, US
25,603
Government relations consulting firm
KENISHA RUSSELL
33,962
+1 202-434-7310
[ "JEREMY RABINOVITZ", "KEVIN MICHAEL KAPPEL" ]
[ 31268, 49033 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/133380/
https://lda.senate.gov/api/v1/registrants/25603/
https://lda.senate.gov/filings/public/filing/32cd105f-168d-453d-b8c0-08100bbb5837/print/
32cd105f-168d-453d-b8c0-08100bbb5837
32cd105f-168d-453d-b8c0-08100bbb5837_25603_133380
astellas pharma us, inc.
2012-10-18T17:18:25
YNCHF
2012-10-22T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152) Issues related to the development of new antibiotics. Issues related to drug safety. S. 1734, Generating Antibiotic Incentives Now Act of 2011. S. 3187, the Food and Drug Administration Safety and Innovation Act, now Public Law No: 112-144.", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152)." ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2012-Q3
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ (Chief of Staff, Rep. Melissa Bean)", "JONATHON JONES (Chief of Staff, Senator Carper)", "SHEILA MURPHY (Senior Foreign Policy Advisor, Senator Daschle)", "SEAN RICHARDSON (Staff Assistant, Rep. Dick Gephardt)", "JOHN MICHAEL GONZALEZ (Chief of Staff, Rep. Melissa Bean)", "JONATHON JONES (Chief of Staff, Senator Carper)", "SHEILA MURPHY (Senior Foreign Policy Advisor, Senator Daschle)", "SEAN RICHARDSON (Staff Assistant, Rep. Dick Gephardt)" ]
[ 47178, 26450, 41354, 6542, 47178, 26450, 41354, 6542 ]
[ "Chief of Staff, Rep. Melissa Bean", "Chief of Staff, Senator Carper", "Senior Foreign Policy Advisor, Senator Daschle", "Staff Assistant, Rep. Dick Gephardt", "Chief of Staff, Rep. Melissa Bean", "Chief of Staff, Senator Carper", "Senior Foreign Policy Advisor, Senator Daschle", "Staff Assistant, Rep. Dick Gephardt" ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/1350e0df-5517-42a0-953f-de8a94a78de5/print/
1350e0df-5517-42a0-953f-de8a94a78de5
1350e0df-5517-42a0-953f-de8a94a78de5_20744_127151
astellas pharma us, inc.
2012-10-22T20:54:39
YNCHF
2012-10-22T00:00:00
astellas pharma us, inc.
null
560,000
a
service_provided
[ "Issues related to the Tariff bills (H.R. 5345; H.R. 5357; H.R. 5358; H.R. 5359; H.R. 5364).", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152)\nIssues related to the development of new antibiotics (the Generating Antibiotic Incentives Now Act (H.R. 2182) (S.1734))\nIssues related to implementation of the Prescription Drug User Fee Act (now Public Law 112-144)", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152).\nIssues related to Medicare covering immunosuppressants for ESRD patients post transplant (H.R. 2969)." ]
[ "TAX - Taxation/Internal Revenue Code", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2012-Q3
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "RYAN AMBROSE (House Committee on Energy & Commerce, Clerk)", "MARY LACEY REUTHER", "RYAN AMBROSE (House Committee on Energy & Commerce, Clerk)", "MARY LACEY REUTHER", "RYAN AMBROSE (House Committee on Energy & Commerce, Clerk)" ]
[ 54800, 55562, 54800, 55562, 54800, 55562 ]
[ null, "House Committee on Energy & Commerce, Clerk", null, "House Committee on Energy & Commerce, Clerk", null, "House Committee on Energy & Commerce, Clerk" ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/0ed39f66-5cd0-4f42-9b36-d36f1ad28c6d/print/
0ed39f66-5cd0-4f42-9b36-d36f1ad28c6d
0ed39f66-5cd0-4f42-9b36-d36f1ad28c6d_40032268_188248
astellas pharma us, inc.
2012-10-22T21:37:03
YNCHF
2012-10-22T00:00:00
astellas pharma us, inc.
pharmaceutical company
30,000
lobbying_income
service_provided
[ "General reimbursement issues", "The Federal, Food, Drug and Cosmetic Act\nThe Prescription Drug User Fee Act (PDUFA)\nGenerating Antibiotic Incentives Now (GAIN) Act\nPatient Protection and Affordable Care Act\nFDA Safety & Innovation Act" ]
[ "MMM - Medicare/Medicaid", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2012-Q3
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "RICHARD CHARLES WHITE (Legislative Coordinator, Sen. John Charles)", "STEVEN E IRIZARRY (Counsel, Senate HELP and Sen. Chuck Hagel)", "RICHARD CHARLES WHITE (Legislative Coordinator, Sen. John Charles)", "STEVEN E IRIZARRY (Counsel, Senate HELP and Sen. Chuck Hagel)" ]
[ 54777, 56477, 54777, 56477 ]
[ "Legislative Coordinator, Sen. John Charles", "Counsel, Senate HELP and Sen. Chuck Hagel", "Legislative Coordinator, Sen. John Charles", "Counsel, Senate HELP and Sen. Chuck Hagel" ]
[ true, true, true, true ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/042347de-152e-4b74-bc10-d34d10252567/print/
042347de-152e-4b74-bc10-d34d10252567
042347de-152e-4b74-bc10-d34d10252567_400762305_195037
astellas pharma us, inc.
2012-10-22T21:40:24
YNCHF
2013-01-17T00:00:00
astellas pharma us
Pharmaceutical company
25,000
lobbying_income
service_provided
[ "PHARMACEUTICAL AND LIFE SCIENCES ISSUES", "REIMBURSEMENT ISSUES" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2012-Q4
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "JOHN HERZOG (HEALTH AIDE, SEN. LAMAR ALEXANDER)", "JEFFREY J KIMBELL", "JODIE LOCKHART", "JOHN HERZOG (HEALTH AIDE, SEN. LAMAR ALEXANDER)" ]
[ 42442, 51434, 53650, 42442, 51434, 53650 ]
[ null, null, "HEALTH AIDE, SEN. LAMAR ALEXANDER", null, null, "HEALTH AIDE, SEN. LAMAR ALEXANDER" ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/91bf10e9-4446-4376-a97b-643d0a26848b/print/
91bf10e9-4446-4376-a97b-643d0a26848b
91bf10e9-4446-4376-a97b-643d0a26848b_46038_153900
astellas pharma us
2013-01-17T20:07:07
YNCHF
2013-01-18T00:00:00
astellas pharma us, inc.
null
50,000
lobbying_income
service_provided
[ "Miscellaneous Tariff Bill (MTB).", "Issues relating to the implementation of the Affordable Health Care Act; Issues related to drug safety and drug shortages." ]
[ "TRD - Trade (domestic/foreign)", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2012-Q4
2007-07-01
null
IL
US
1,002,983
0
null
2024-01-30T12:37:26.892278-05:00
ML STRATEGIES, LLC
555 12th Street NW, Suite 1100, Washington, DC, 20004, US
25,603
Government relations consulting firm
KENISHA RUSSELL
33,962
+1 202-434-7310
[ "ROBERT NEAL MARTIN (Legislative Assistant, U. S. Senator Max Cleland)", "JEREMY RABINOVITZ", "KEVIN MICHAEL KAPPEL", "JEREMY RABINOVITZ", "KEVIN MICHAEL KAPPEL" ]
[ 145323, 31268, 49033, 31268, 49033 ]
[ "Legislative Assistant, U. S. Senator Max Cleland", null, null, null, null ]
[ true, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/133380/
https://lda.senate.gov/api/v1/registrants/25603/
https://lda.senate.gov/filings/public/filing/44bbcc23-5dda-44c9-9fea-449c6c9ba93b/print/
44bbcc23-5dda-44c9-9fea-449c6c9ba93b
44bbcc23-5dda-44c9-9fea-449c6c9ba93b_25603_133380
astellas pharma us, inc.
2013-01-18T15:09:12
YNCHF
2013-01-22T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152) Issues related to the development of new antibiotics. Issues related to drug safety.", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152)." ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2012-Q4
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY", "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY" ]
[ 47178, 26450, 41354, 47178, 26450, 41354 ]
[ null, null, null, null, null, null ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/5954314a-5582-45f4-8315-aac723846244/print/
5954314a-5582-45f4-8315-aac723846244
5954314a-5582-45f4-8315-aac723846244_20744_127151
astellas pharma us, inc.
2013-01-22T17:29:39
YNCHF
2013-01-22T00:00:00
astellas pharma us, inc.
null
400,000
a
service_provided
[ "Issues related to the Tariff bills (H.R. 5345; H.R. 5357; H.R. 5358; H.R. 5359; H.R. 5364).", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152)", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152).\nIssues related to Medicare covering immunosuppressants for ESRD patients post transplant (H.R. 2969)." ]
[ "TAX - Taxation/Internal Revenue Code", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2012-Q4
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "RYAN AMBROSE (House Committee on Energy & Commerce, Clerk)", "MARY LACEY REUTHER", "RYAN AMBROSE (House Committee on Energy & Commerce, Clerk)", "MARY LACEY REUTHER", "RYAN AMBROSE (House Committee on Energy & Commerce, Clerk)" ]
[ 54800, 55562, 54800, 55562, 54800, 55562 ]
[ null, "House Committee on Energy & Commerce, Clerk", null, "House Committee on Energy & Commerce, Clerk", null, "House Committee on Energy & Commerce, Clerk" ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/7670fb82-929e-4b16-89f6-68ca3c5437e0/print/
7670fb82-929e-4b16-89f6-68ca3c5437e0
7670fb82-929e-4b16-89f6-68ca3c5437e0_40032268_188248
astellas pharma us, inc.
2013-01-22T20:33:40
YNCHF
2013-01-22T00:00:00
astellas pharma us, inc.
pharmaceutical company
30,000
lobbying_income
service_provided
[ "Issues involving:\nThe Federal, Food, Drug and Cosmetic Act\nThe Prescription Drug User Fee Act (PDUFA)\nGenerating Antibiotic Incentives Now (GAIN) Act\nPatient Protection and Affordable Care Act", "General reimbursement issues" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2012-Q4
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "RICHARD CHARLES WHITE (Legislative Coordinator, Sen. John Charles)", "STEVEN E IRIZARRY (Counsel, Senate HELP and Sen. Chuck Hagel)", "RICHARD CHARLES WHITE (Legislative Coordinator, Sen. John Charles)", "STEVEN E IRIZARRY (Counsel, Senate HELP and Sen. Chuck Hagel)" ]
[ 54777, 56477, 54777, 56477 ]
[ "Legislative Coordinator, Sen. John Charles", "Counsel, Senate HELP and Sen. Chuck Hagel", "Legislative Coordinator, Sen. John Charles", "Counsel, Senate HELP and Sen. Chuck Hagel" ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/bea4d685-df79-4dc1-bcf0-e6e4aeca0b93/print/
bea4d685-df79-4dc1-bcf0-e6e4aeca0b93
bea4d685-df79-4dc1-bcf0-e6e4aeca0b93_400762305_195037
astellas pharma us, inc.
2013-01-22T22:50:00
YNCHF
2013-04-15T00:00:00
astellas pharma us, inc.
Biotechnology pharmaceutical product discovery and development.
7,500
lobbying_income
service_provided
[ "General health care coverage and reimbursement; issues related to infectious disease drug development, procurement and regulation." ]
[ "HCR - Health Issues" ]
[ "136 - Centers For Medicare and Medicaid Services (CMS)", "135 - Food & Drug Administration (FDA)", "34 - Health & Human Services, Dept of (HHS)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q1
2013-01-01
null
IL
US
202
0
0
2024-01-19T13:20:04.069302-05:00
EAST END GROUP, LLC
1000 Wisconsin Ave., NW, Suite 200, Wasington, DC, 20007, US
400,646,949
Consulting and government affairs.
KELLY CHILDRESS
400,646,949
+1 202-688-1814
[ "BARRETT THORNHILL" ]
[ 52414 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/193827/
https://lda.senate.gov/api/v1/registrants/400646949/
https://lda.senate.gov/filings/public/filing/635ba9b0-476d-4221-a1ac-6b084add145b/print/
635ba9b0-476d-4221-a1ac-6b084add145b
635ba9b0-476d-4221-a1ac-6b084add145b_400646949_193827
astellas pharma us, inc.
2013-04-15T14:35:28
YNCHF
2013-04-16T00:00:00
astellas pharma us
Pharmaceutical company
25,000
lobbying_income
service_provided
[ "PHARMACEUTICAL AND LIFE SCIENCES ISSUES", "REIMBURSEMENT ISSUES" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q1
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "JOHN HERZOG (HEALTH AIDE, SEN. LAMAR ALEXANDER)", "JEFFREY J KIMBELL", "JODIE LOCKHART", "JOHN HERZOG (HEALTH AIDE, SEN. LAMAR ALEXANDER)" ]
[ 42442, 51434, 53650, 42442, 51434, 53650 ]
[ null, null, "HEALTH AIDE, SEN. LAMAR ALEXANDER", null, null, "HEALTH AIDE, SEN. LAMAR ALEXANDER" ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/135510e1-d1eb-4edb-aca6-b2a042a3cae0/print/
135510e1-d1eb-4edb-aca6-b2a042a3cae0
135510e1-d1eb-4edb-aca6-b2a042a3cae0_46038_153900
astellas pharma us
2013-04-16T15:13:37
YNCHF
2013-04-17T00:00:00
astellas pharma us, inc.
null
50,000
lobbying_income
service_provided
[ "Issues relating to the implementation of the Affordable Health Care Act; Issues related to drug safety and drug shortages; Issues relating to oncology.", "Miscellaneous Tariff Bill (MTB)." ]
[ "HCR - Health Issues", "TRD - Trade (domestic/foreign)" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q1
2007-07-01
null
IL
US
1,002,983
0
null
2024-01-30T12:37:26.892278-05:00
ML STRATEGIES, LLC
555 12th Street NW, Suite 1100, Washington, DC, 20004, US
25,603
Government relations consulting firm
KENISHA RUSSELL
33,962
+1 202-434-7310
[ "JEREMY RABINOVITZ", "KEVIN MICHAEL KAPPEL", "JEREMY RABINOVITZ", "KEVIN MICHAEL KAPPEL", "ROBERT NEAL MARTIN" ]
[ 31268, 49033, 31268, 49033, 145323 ]
[ null, null, null, null, null ]
[ false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/133380/
https://lda.senate.gov/api/v1/registrants/25603/
https://lda.senate.gov/filings/public/filing/4388efe0-d66a-43cf-b18a-f035cc18690a/print/
4388efe0-d66a-43cf-b18a-f035cc18690a
4388efe0-d66a-43cf-b18a-f035cc18690a_25603_133380
astellas pharma us, inc.
2013-04-17T15:28:22
YNCHF
2013-04-22T00:00:00
astellas pharma us, inc.
pharmaceutical company
30,000
lobbying_income
service_provided
[ "Issues involving:\nThe Federal, Food, Drug and Cosmetic Act\nThe Prescription Drug User Fee Act (PDUFA)\nPatient Protection and Affordable Care Act\nThe Food and Drug Administration Safety and Innovation Act (FDASIA)", "General reimbursement issues" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q1
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "STEVEN E IRIZARRY", "RICHARD CHARLES WHITE", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "RICHARD CHARLES WHITE", "VINCENT A. ROBERTI, SR." ]
[ 56477, 54777, 64580, 56477, 54777, 64580 ]
[ null, null, null, null, null, null ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/b35e5a9c-7246-42d7-8065-6b206efe4bd1/print/
b35e5a9c-7246-42d7-8065-6b206efe4bd1
b35e5a9c-7246-42d7-8065-6b206efe4bd1_400762305_195037
astellas pharma us, inc.
2013-04-22T15:33:22
YNCHF
2013-04-22T00:00:00
astellas pharma us, inc.
null
650,000
a
service_provided
[ "Issues related to the Tariff bills (H.R. 5345; H.R. 5357; H.R. 5358; H.R. 5359; H.R. 5364).", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152)", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152).\nIssues related to Medicare covering immunosuppressants for ESRD patients post transplant (H.R. 2969)." ]
[ "TAX - Taxation/Internal Revenue Code", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q1
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "RYAN AMBROSE (House Committee on Energy & Commerce, Clerk)", "MARY LACEY REUTHER", "RYAN AMBROSE (House Committee on Energy & Commerce, Clerk)", "MARY LACEY REUTHER", "RYAN AMBROSE (House Committee on Energy & Commerce, Clerk)" ]
[ 54800, 55562, 54800, 55562, 54800, 55562 ]
[ null, "House Committee on Energy & Commerce, Clerk", null, "House Committee on Energy & Commerce, Clerk", null, "House Committee on Energy & Commerce, Clerk" ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/c2cce90a-ab73-4015-b5fe-339df7f70849/print/
c2cce90a-ab73-4015-b5fe-339df7f70849
c2cce90a-ab73-4015-b5fe-339df7f70849_40032268_188248
astellas pharma us, inc.
2013-04-22T17:33:04